Hypo-osmolality and hyponatraemia

E4_HYPOOSMNAT

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — E87.1 Hospital discharge: ICD-9 — 2761 Cause of death: ICD-10 — E87.1 Cause of death: ICD-9 — 2761 2 out of 7 registries used, show all original rules.	9601
4. Check minimum number of events None	9601
5. Include endpoints None	9601
6. Filter based on genotype QC (FinnGen only)	8550

Control definitions (FinnGen only)

Control exclude: E4_METABOLIA

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: E87
Name in latin: Hyposmolalitas

NAME	E4_HYPOOSMNAT
CONTROL_EXCLUDE	E4_METABOLIA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E871
HD_ICD_9	2761
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	E871
COD_ICD_9	2761
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Hypo-osmolality and hyponatraemia based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	74063	47522	26119
Only index persons	63818	41374	22444
Unadjusted period prevalence (%)
Whole population	1.13	1.36	0.73
Only index persons	1.29	1.52	0.86
Median age at first event (years)
Whole population	73.12	77.26	65.64
Only index persons	73.08	77.07	65.73

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	8550	4964	3586
Unadjusted period prevalence (%)	1.71	1.76	1.64
Median age at first event (years)	70.85	72.40	68.71

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
8740: Matched controls
86696

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.8

320.1

1943

7924

N07BB01

ATC

disulfiram; oral

5.7

317.3

617

1135

N03AX14

ATC

levetiracetam; systemic

6.2

317.3

562

945

C07AB07

ATC

bisoprolol; oral

2.3

314.5

5334

34681

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

13.9

313.4

293

216

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.4

307.7

1673

5684

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

36351.8

307.7

8679

338

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.6

307.7

3396

17109

R53

ICD-10 Finland

Malaise and fatigue

3.2

307.7

3367

14314

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.5

307.7

2492

8793

R56.8

ICD-10 Finland

Other and unspecified convulsions

6.9

307.7

1032

1653

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

4.6

307.7

882

2053

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

4.0

307.7

3387

11874

AA1AD

NOMESCO Finland

CT of head and brain

3.7

307.7

4376

18292

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.4

307.7

3927

21842

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

7.8

307.7

1436

2125

N03AG01

ATC

valproic acid; systemic, rectal

4.4

307.7

896

2183

C08CA01

ATC

amlodipine; oral

2.5

307.7

4602

26852

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

8.2

307.7

504

646

R11

ICD-10 Finland

Nausea and vomiting

3.9

307.7

1410

4037

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

5.7

307.7

806

1531

E87.5

ICD-10 Finland

Hyperkalaemia

29.6

307.7

520

185

E87.6

ICD-10 Finland

Hypokalaemia

29.0

307.7

1014

391

G40.9

ICD-10 Finland

Epilepsy, unspecified

6.1

307.7

649

1126

N17.9

ICD-10 Finland

Acute renal failure, unspecified

5.2

307.7

759

1556

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.9

307.7

5493

32181

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.5

307.7

3437

17836

C03DA01

ATC

spironolactone; oral

3.1

307.7

1862

6880

E86

ICD-10 Finland

Volume depletion

50.8

307.7

539

112

H02AB09

ATC

hydrocortisone; systemic

8.1

307.7

474

612

D64.9

ICD-10 Finland

Anaemia, unspecified

3.3

307.7

1780

6211

P15

ICPC

Chronic alcohol abuse

7.4

307.7

530

750

N05BA04

ATC

oxazepam; oral

2.5

307.7

3122

15525

C03CA01

ATC

furosemide; systemic

2.9

307.7

4457

22880

N06AX11

ATC

mirtazapine; oral

2.5

307.7

3798

20507

F10.25

ICD-10 Finland

Alcohol dependence continuous use

11.5

307.7

424

384

N05AH04

ATC

quetiapine; oral

3.0

307.7

2054

7995

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

12.3

306.4

308

256

A28

ICPC

Limited function/disability NOS

2.5

304.7

2600

12515

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

7.3

303.4

457

648

N03AF02

ATC

oxcarbazepine; oral

5.9

302.8

567

1006

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.0

302.2

1621

6166

N05CF01

ATC

zopiclone; oral

2.3

301.6

3766

21414

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

13.7

298.1

281

210

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

2.8

296.9

1801

7314

F10.20

ICD-10 Finland

Alcohol dependence currently independent

8.5

295.6

392

479

F10.24

ICD-10 Finland

Alcohol depence active use

10.8

294.8

323

306

I10

ICD-10 Finland

Essential (primary) hypertension

2.5

293.5

6447

46206

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

17.9

292.9

239

136

I50.9

ICD-10 Finland

Heart failure, unspecified

2.6

291.3

2154

9659

N05AH03

ATC

olanzapine; systemic

4.1

284.0

832

2147

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.7

281.9

1964

8538

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

131.1

281.5

143

A06AD11

ATC

lactulose; oral

2.6

280.8

2123

9602

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

9.5

273.9

329

354

T36

ICD-10 Finland

Poisoning by systemic antibiotics

5.5

272.2

553

1057

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.5

269.8

2103

9629

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.8

269.3

1650

6706

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.1

265.8

1289

4609

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

13.4

265.0

253

193

JN3AD

NOMESCO Finland

Abdominal CT examination

2.8

263.2

1626

6630

E22.2

ICD-10 Finland

Syndrome of inappropriate secretion of antidiuretic hormone

75.3

262.6

142

N05BA01

ATC

diazepam; systemic, rectal

2.7

255.8

1618

6670

L28

ICPC

Limited function/disability (L)

2.3

254.5

2480

12513

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.5

252.5

2041

9469

SPAT1254

SPAT

Administration of medicine

2.5

250.2

1931

8764

WX892

NOMESCO Finland

Monitored bed care

3.4

247.8

1004

3218

A02BC02

ATC

pantoprazole; systemic

2.3

244.5

6535

48756

R63.1

ICD-10 Finland

Polydipsia

42.4

243.8

147

E87.8

ICD-10 Finland

Other disorders of electrolyte and fluid balance, not elsewhere classified

63.8

239.6

133

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

6.5

239.4

399

629

TPH04

NOMESCO Finland

Cathetrisation of vein

2.3

236.0

2339

11830

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

3.5

234.5

904

2804

A04

ICPC

Weakness/tiredness general

2.4

224.3

1869

8740

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.4

221.6

2004

9711

R41.0

ICD-10 Finland

Disorientation, unspecified

4.3

220.8

597

1444

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

6.5

219.9

367

579

F10.09

ICD-10 Finland

Alcohol intoxication UNS

7.2

217.6

330

470

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

7.7

216.9

310

413

R33

ICD-10 Finland

Retention of urine

3.0

216.0

1086

3939

N02AA05

ATC

oxycodone; systemic

2.2

214.2

2360

12398

N05AA02

ATC

levomepromazine; systemic

4.3

213.3

578

1400

N30.0

ICD-10 Finland

Acute cystitis

2.3

211.9

2019

9982

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.0

207.4

3900

24926

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

5.7

206.6

393

705

C08CA13

ATC

lercanidipine; oral

2.4

205.0

1823

8736

F05.9

ICD-10 Finland

Delirium, unspecified

5.0

196.0

440

915

R55

ICD-10 Finland

Syncope and collapse

2.5

190.3

1400

6143

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.3

189.8

1659

7865

N05AX08

ATC

risperidone; systemic

2.7

189.2

1192

4852

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

8.2

188.0

252

311

R06.0

ICD-10 Finland

Dyspnoea

2.0

187.1

2822

16548

N06AB04

ATC

citalopram; systemic

2.2

186.0

2133

11293

N05CD07

ATC

temazepam; oral

2.4

185.1

1537

7118

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

3.1

181.6

810

2733

ZXD05

NOMESCO Finland

Urgent procedure

2.0

181.4

2750

16121

TPH07

NOMESCO Finland

Cathetrisation of artery

2.5

179.7

1277

5503

K70.1

ICD-10 Finland

Alcoholic hepatitis

14.5

178.4

162

113

R42

ICD-10 Finland

Dizziness and giddiness

2.0

173.2

2557

14804

C02AC05

ATC

moxonidine; oral

3.5

171.3

628

1876

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

6.7

170.9

275

417

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

10.4

170.4

190

184

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

10.7

170.4

187

177

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.9

170.2

3252

20526

N05AF03

ATC

chlorprothixene; systemic

5.2

170.1

358

703

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

8.3

167.9

223

272

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.0

167.3

2372

13512

SPAT1263

SPAT

Sampling

1.9

167.0

3907

26263

N03AX16

ATC

[U] pregabalin

2.0

166.3

2291

12911

P16

ICPC

Acute alcohol abuse

7.4

166.1

245

338

B01AC04

ATC

clopidogrel; oral

2.2

164.6

1608

7944

E83.51

ICD-10 Finland

Hypocalcemia

32.2

163.4

106

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.7

161.7

996

3993

N05BA06

ATC

lorazepam; systemic, sublingual

3.1

161.4

736

2510

SPAT1301

SPAT

No procedures

1.9

161.1

3180

20197

N03AF01

ATC

carbamazepine; oral, rectal

3.2

159.4

662

2136

G72.8

ICD-10 Finland

Other specified myopathies

5.6

156.8

304

554

N06AX16

ATC

venlafaxine; oral

2.4

156.3

1229

5524

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.4

155.7

1181

5223

SPAT1262

SPAT

Handing over of treatment supplies

2.1

155.0

1782

9364

N03AX09

ATC

lamotrigine; oral

4.0

154.6

451

1150

A10AB05

ATC

insulin aspart; parenteral

2.9

153.7

803

2952

F20.9

ICD-10 Finland

Schizophrenia, unspecified

5.6

151.7

293

532

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

13.0

151.4

146

113

JN4AD

NOMESCO Finland

Body CT examination

2.3

150.7

1352

6427

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.0

150.7

702

2421

K59.09

ICD-10 Finland

Constipation, unspecified

2.7

149.2

877

3428

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.6

149.1

935

3775

205

Kela drug reimbursment

Chronic hypertension

1.9

149.1

2924

18429

I25.1

ICD-10 Finland

Atherosclerotic heart disease

2.0

148.4

2225

12839

A10AE04

ATC

insulin glargine; parenteral

2.6

147.2

980

4072

E27.1

ICD-10 Finland

Primary adrenocortical insufficiency

27.9

147.1

100

S06.0

ICD-10 Finland

Concussion

2.4

146.7

1169

5276

E0000UV, ,

ATC

1.8

146.5

3790

25944

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.9

146.0

720

2563

TKC20

NOMESCO Finland

Catheterisation of bladder

2.7

145.7

840

3249

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.9

145.6

725

2594

J01MA02

ATC

ciprofloxacin; systemic

1.8

145.4

3734

25491

R60.0

ICD-10 Finland

Localized oedema

2.2

144.8

1481

7417

N03AX18

ATC

lacosamide; systemic

10.2

144.1

163

161

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

7.4

141.4

207

283

XF400

NOMESCO Finland

ECG with 12 standard connections

2.1

141.3

1589

8250

N02BE01

ATC

paracetamol; systemic, rectal

2.5

141.2

7895

68432

I50.0

ICD-10 Finland

Congestive heart failure

2.4

139.9

1036

4519

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.3

139.8

572

1826

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.4

139.2

1137

5181

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.5

139.0

983

4198

F29

ICD-10 Finland

Unspecified nonorganic psychosis

4.3

138.0

369

881

EBA15

NOMESCO Finland

Extraction of multiple teeth

3.5

137.9

508

1518

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

3.3

137.8

563

1795

N05BA02

ATC

chlordiazepoxide; systemic

4.5

136.6

344

784

J01DB01

ATC

cefalexin; oral

2.0

135.6

7081

59085

A03FA01

ATC

metoclopramide; systemic, rectal

1.9

135.4

2189

12894

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

3.0

135.3

625

2142

N06AB10

ATC

escitalopram; oral

2.1

134.1

1628

8681

H02AB06

ATC

prednisolone; systemic

1.7

133.3

4341

31451

R07.4

ICD-10 Finland

Chest pain, unspecified

1.8

132.7

2647

16646

J01MA12

ATC

levofloxacin; systemic

2.0

132.5

1885

10627

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

4.9

132.1

295

609

N02AX02

ATC

tramadol; systemic, rectal

1.7

131.6

3919

27664

SPAT1216

SPAT

Assessment of functional ability

2.0

131.5

1852

10401

127

Kela drug reimbursment

Transplant complication

6.9

131.2

206

304

C09AA05

ATC

ramipril; oral

1.8

131.2

2538

15801

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.3

131.1

1127

5242

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

5.6

129.5

249

450

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.5

128.7

904

3842

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.0

128.6

1800

10079

SPAT1229

SPAT

Assessment of need for aid

2.4

128.0

994

4421

UJF32

NOMESCO Finland

Coloscopy

1.8

127.4

2604

16457

X59

ICD-10 Finland

Exposure to unspecified factor

2.0

127.3

1781

9967

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.9

127.3

2058

12088

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.8

125.8

2503

15679

A41.9

ICD-10 Finland

Sepsis, unspecified

3.3

125.8

496

1546

WX882

NOMESCO Finland

High dependency care

4.0

124.8

372

962

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.8

124.5

2321

14246

N06AX21

ATC

duloxetine; oral

2.3

123.3

1111

5262

S97

ICPC

Chronic ulcer skin

2.6

123.1

797

3257

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.3

122.4

1096

5176

Z72.1

ICD-10 Finland

Alcohol use

7.2

122.0

183

257

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.6

121.3

760

3055

T89

ICPC

Diabetes insulin dependent

3.8

120.7

375

999

N30.9

ICD-10 Finland

Cystitis, unspecified

2.5

120.4

821

3437

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.3

120.3

986

4485

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.8

120.3

2679

17309

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.0

119.3

1538

8344

C10AA01

ATC

simvastatin; oral

1.7

119.0

3833

27396

N03AX12

ATC

[U] gabapentin; oral

2.0

118.8

1532

8313

S01.0

ICD-10 Finland

Open wound of scalp

2.4

118.7

932

4159

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.4

118.4

868

3756

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.5

118.2

785

3245

A06AC01

ATC

ispaghula (psylla seeds); oral

1.8

117.9

2614

16847

Z94.0

ICD-10 Finland

Kidney transplant status

8.0

117.9

161

203

R03BB04

ATC

tiotropium bromide; inhalant

2.2

117.5

1097

5265

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.1

117.4

508

1674

L04AD02

ATC

tacrolimus; systemic

9.0

117.3

146

164

C07AB02

ATC

metoprolol; systemic

1.8

116.9

2127

12918

N05AX12

ATC

aripiprazole; systemic

4.1

116.7

329

817

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

3.4

116.3

448

1375

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

19.4

116.3

P29

ICPC

Psychological sympt/compl other

2.9

115.8

565

1993

C07AA05

ATC

propranolol; systemic

1.9

115.1

1683

9524

E23.00

ICD-10 Finland

Panhypopituitarism

15.0

115.0

102

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

13.0

115.0

111

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

5.2

114.7

238

461

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

9.7

114.3

134

139

SPAT1234

SPAT

Support of social functional capacity

2.6

114.0

725

2933

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

7.1

114.0

173

246

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.9

112.5

562

2008

W19

ICD-10 Finland

Unspecified fall

2.2

112.3

1094

5336

R50.9

ICD-10 Finland

Fever, unspecified

2.0

112.0

1416

7614

N05AH02

ATC

clozapine; systemic

5.9

110.9

200

340

N06AB06

ATC

sertraline; oral

2.3

110.8

956

4436

WX730

NOMESCO Finland

Conventional respirator

5.1

109.9

233

460

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.3

109.7

936

4323

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.8

109.6

2160

13400

SPAT1167

SPAT

Insertion of urinary catheter

3.2

109.5

454

1457

F10.41

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol with seizures

19.1

109.2

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.4

108.7

840

3716

E87.2

ICD-10 Finland

Acidosis

540.5

108.7

108

WZC00

NOMESCO Finland

Treatment plan or consultation

1.7

108.0

3142

21705

ZX120

NOMESCO Finland

Intravenous

2.3

106.2

914

4234

C01DA14

ATC

isosorbide mononitrate; oral

1.9

106.1

1632

9362

R51.80

ICD-10 Finland

Headache

2.0

105.6

1248

6541

N04AA02

ATC

biperiden; systemic

4.5

105.5

260

582

K92.1

ICD-10 Finland

Melaena

2.6

105.0

653

2610

TK800

NOMESCO Finland

Hemodialysis

4.7

104.6

247

534

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.9

103.8

1727

10151

A46

ICD-10 Finland

Erysipelas

1.9

103.8

1540

8726

WX872

NOMESCO Finland

Intensive care

2.9

103.6

518

1850

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

3.6

102.3

354

1014

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

4.1

101.8

282

691

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

101.2

3370

23992

C03AA03

ATC

hydrochlorothiazide; oral

2.1

101.0

1029

5096

A29

ICPC

General symptom/complaint other

1.9

100.8

1411

7835

SPAT1240

SPAT

Therapeutic discussion

2.4

100.7

770

3387

G40

ICD-10 Finland

Epilepsy

7.2

100.3

149

207

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.1

99.6

1016

5033

V03AA01, ,

ATC

5.2

99.5

206

398

SPAT1260

SPAT

Consultation of another employee

1.8

99.3

1686

9959

K70.4

ICD-10 Finland

Alcoholic hepatic failure

12.3

99.2

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

99.1

2666

17949

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.7

98.9

575

2222

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.3

98.7

815

3705

I95.1

ICD-10 Finland

Orthostatic hypotension

2.8

98.7

527

1949

L04AA06

ATC

mycophenolic acid; systemic

4.9

98.3

219

451

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

97.7

1476

8396

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.5

97.6

342

987

A02BC05

ATC

esomeprazole; systemic

1.6

96.6

3511

25458

N17.8

ICD-10 Finland

Other acute renal failure

5.7

96.0

181

321

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.1

96.0

971

4791

J01EA01

ATC

trimethoprim; systemic

1.7

94.9

2496

16668

183

Kela drug reimbursment

Lamotrigin and topiramate

8.0

94.7

129

162

A11CC03

ATC

alfacalcidol; systemic

4.3

94.5

247

579

J45.9

ICD-10 Finland

Asthma, unspecified

1.8

94.4

1719

10354

R02

ICPC

Shortness of breath/dyspnoea

1.9

94.2

1323

7339

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.8

93.8

1700

10222

WW500

NOMESCO Finland

Blood transfusion

2.9

93.1

463

1647

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.1

92.9

982

4924

N05BE01

ATC

buspirone; oral

3.6

92.9

318

904

103

Kela drug reimbursment

Diabetes, insulin-treated

1.7

92.8

2432

16204

K92.0

ICD-10 Finland

Haematemesis

3.5

92.4

322

926

K70.0

ICD-10 Finland

Alcoholic fatty liver

7.3

92.3

137

190

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

92.2

3308

23832

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

9.2

92.1

112

122

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

7.5

92.1

132

176

F10.03

ICD-10 Finland

Alcohol-related acute intoxication with delirium

13.7

92.0

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.9

91.7

1244

6817

WZC30

NOMESCO Finland

Teaching

1.8

91.6

1498

8722

G41.9

ICD-10 Finland

Status epilepticus, unspecified

8.4

91.5

120

144

Z51.5

ICD-10 Finland

Palliative care

2.0

91.5

1060

5497

P72

ICPC

Schizophrenia

4.6

91.4

219

479

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

4.4

90.7

235

547

V03AE01

ATC

polystyrene sulfonate; oral

5.5

90.6

176

321

SPAT1265

SPAT

Breathalyser

7.7

90.6

128

168

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

4.2

90.3

247

599

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.6

89.9

577

2338

N05AF05

ATC

zuclopenthixol; systemic

6.6

89.6

145

221

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.3

89.5

756

3465

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.2

88.9

362

1148

A02BC01

ATC

omeprazole; systemic

1.7

88.9

2501

16937

J01FF01

ATC

clindamycin; systemic

1.7

88.4

2272

15030

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.5

87.6

597

2488

T90

ICPC

Diabetes non-insulin dependent

1.7

86.7

2142

14011

XF600

NOMESCO Finland

Bloodpressure measurement

2.4

86.2

619

2642

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

4.4

86.2

217

494

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.9

86.0

263

692

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

4.1

85.4

243

607

U05

ICPC

Urination problems other

2.4

85.3

621

2667

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.1

85.1

940

4783

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.8

85.1

1604

9727

N05AB03

ATC

perphenazine; systemic, rectal

3.1

84.5

363

1188

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.1

84.4

872

4327

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

8.8

84.1

106

121

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.6

83.8

2650

18421

Z2446

NOMESCO Finland

Social worker

2.5

83.7

574

2398

A10AC01

ATC

insulin (human); parenteral

2.3

82.9

697

3185

P03

ICPC

Feeling depressed

2.3

82.6

653

2906

SPAT1310

SPAT

Counselling related to known health issue

1.6

82.4

2701

18920

C08CA02

ATC

felodipine; oral

2.0

82.3

1041

5556

S42.2

ICD-10 Finland

Fracture of upper end of humerus

2.4

81.8

606

2621

C09CA01

ATC

losartan; oral

1.6

81.7

2463

16901

M54.5

ICD-10 Finland

Low back pain

1.6

81.4

2919

20868

N06AA09

ATC

amitriptyline; systemic

2.0

81.4

938

4843

P99

ICPC

Psychological disorders other

3.7

81.4

265

728

N06AX03

ATC

mianserin; oral

2.6

81.3

506

2018

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.5

81.0

537

2207

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

13.9

81.0

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.9

80.8

408

1462

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

80.8

1570

9589

J01CA08

ATC

pivmecillinam; oral

1.5

80.7

3534

26420

A10AE05

ATC

insulin detemir; parenteral

2.7

80.5

471

1822

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

8.5

80.2

104

123

C09AA02

ATC

enalapril; systemic

1.7

80.2

1896

12220

UKC02

NOMESCO Finland

Cystoscopy

1.8

80.1

1526

9264

B03XA02

ATC

darbepoetin alfa; parenteral

3.8

79.7

245

647

A01

ICPC

Pain general/multiple sites

2.0

79.5

991

5259

Z3231

NOMESCO Finland

Registered nurse

1.6

79.2

2271

15373

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.6

79.0

493

1969

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.7

78.4

448

1713

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

5.2

78.4

164

320

105

Kela drug reimbursment

Adrenal cortical hypofunction

17.1

78.3

AN1

Coronary angiography

2.0

78.2

950

4994

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.6

78.2

2267

15378

B01AB05

ATC

enoxaparin; parenteral

1.6

77.8

2820

20162

N06AB03

ATC

fluoxetine; oral

2.0

77.7

1013

5457

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.9

77.6

1074

5902

H02AA02

ATC

fludrocortisone; oral

5.6

77.6

147

262

K85.2

ICD-10 Finland

Alcohol-induced acute pancreatitis

9.5

77.5

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

4.4

77.5

200

464

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

6.9

77.3

120

175

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.6

76.8

474

1882

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

76.1

1908

12464

137

Kela drug reimbursment

Uraemia requiring dialysis

7.2

75.7

112

155

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.7

75.6

1499

9190

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.7

75.3

1921

12600

SPAT1255

SPAT

Intravenous administration of medicine

2.2

75.2

675

3164

A10AB04

ATC

insulin lispro; parenteral

3.6

75.1

254

716

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.1

74.6

324

1067

C10AA05

ATC

atorvastatin; oral

1.5

74.1

3484

26305

R18

ICD-10 Finland

Ascites

3.5

74.1

265

775

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

9.6

73.8

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

73.7

2055

13774

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

73.5

3963

30771

A12AA04

ATC

calcium carbonate; oral

4.9

73.3

164

339

SPAT1100

SPAT

Long-term monitoring of blood pressure

2.1

73.2

759

3763

H03AA01

ATC

levothyroxine sodium; systemic

1.6

73.2

1988

13234

SPAT1252

SPAT

Overall medication plan or its review

2.1

73.1

737

3615

M05BX04

ATC

denosumab; parenteral

2.1

73.0

774

3870

E23.03

ICD-10 Finland

Lack of ACTH

16.3

72.9

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.7

72.8

395

1470

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.1

72.8

761

3785

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

5.4

72.7

145

271

N19

ICD-10 Finland

Unspecified kidney failure

2.7

72.6

406

1534

R40.2

ICD-10 Finland

Coma, unspecified

5.6

72.4

137

244

K59.0

ICD-10 Finland

Constipation

2.2

72.3

627

2897

B05DA

ATC

Isotonic solutions

7.8

72.3

100

128

B05DB

ATC

Hypertonic solutions

8.4

72.1

112

P01

ICPC

Feeling anxious/nervous/tense

2.1

72.0

693

3339

ZY010

NOMESCO Finland

Hospital outpatient

2.8

71.8

385

1424

2761A

ICD-9 Finland

Disorders of fluid, electrolyte and acid-base balance, Hyposmolality and/or hyponatraemia

+∞

71.7

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.6

71.7

431

1689

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.8

71.5

372

1354

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

71.4

5520

46043

U08

ICPC

Urinary retention

3.4

71.1

266

800

N06AA12

ATC

doxepin; systemic

2.4

71.1

536

2334

101

Kela drug reimbursment

Anterior pituitary hypofunction

7.9

71.1

125

I95.9

ICD-10 Finland

Hypotension, unspecified

4.0

70.8

203

510

R03AC02

ATC

salbutamol; inhalant

1.5

70.7

4283

33956

N06AX26

ATC

vortioxetine; oral

2.3

70.7

567

2535

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.0

70.6

782

3972

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

2.7

70.5

410

1580

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

3.2

70.5

281

879

N05BA12

ATC

alprazolam; oral

2.0

70.5

880

4663

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.1

70.5

703

3433

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

4.3

70.5

185

435

S18

ICPC

Laceration/cut

1.5

70.2

4070

31967

K08.3

ICD-10 Finland

Retained dental root

2.1

70.1

749

3754

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

10.0

70.1

N05BA09

ATC

clobazam; oral

8.6

69.9

103

N03AE01

ATC

clonazepam; systemic

2.3

69.4

555

2479

SPAT1097

SPAT

Recording of ECG

1.7

69.0

1372

8397

N05AD01

ATC

haloperidol; systemic

2.7

68.9

386

1460

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

3.1

68.7

301

996

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.2

68.6

616

2886

ZYC01

NOMESCO Finland

Remote contact by phone

2.3

68.3

528

2323

C07AG02

ATC

carvedilol; oral

2.2

68.3

608

2838

R60.9

ICD-10 Finland

Oedema, unspecified

2.2

68.2

600

2788

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

68.0

3575

27468

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

68.0

1114

6441

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

7.6

67.9

126

K86.1

ICD-10 Finland

Other chronic pancreatitis

5.4

67.9

134

248

U07

ICPC

Urine symptom/complaint other

2.0

67.6

834

4399

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.8

67.3

1163

6832

F61.0

ICD-10 Finland

Mixed personality disorders

5.0

67.2

147

298

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

67.0

3553

27323

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

66.8

2145

14812

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

9.9

66.8

H04AA01

ATC

glucagon; nasal, parenteral

4.6

66.8

160

350

A10AB01

ATC

insulin (human); parenteral

3.1

66.7

294

976

N05AA01

ATC

chlorpromazine; systemic, rectal

4.7

66.5

153

324

N05CF02

ATC

zolpidem; oral

1.7

66.3

1389

8618

N18.8

ICD-10 Finland

Other chronic renal failure

3.3

66.3

251

761

J01MA14

ATC

moxifloxacin; systemic

2.0

66.2

801

4195

102

Kela drug reimbursment

Diabetes insipidus

15.2

65.9

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.1

65.7

288

953

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.5

65.7

431

1761

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

4.6

65.4

156

340

F10.3

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Withdrawal state

10.9

65.2

F60.9

ICD-10 Finland

Personality disorder, unspecified

5.9

65.2

117

198

Z71.8

ICD-10 Finland

Other specified counselling

1.5

65.2

2493

17887

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.7

65.1

1526

9750

N05AB01

ATC

dixyrazine; systemic

4.6

65.0

154

334

ZY000

NOMESCO Finland

Hospital inpatient

5.5

64.5

126

231

188

Kela drug reimbursment

Psychosis requiring demanding treatment

5.7

64.3

120

211

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

64.2

906

4994

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.7

64.1

1222

7379

Z49.2

ICD-10 Finland

Other dialysis

7.1

63.9

135

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

5.7

63.8

119

209

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

3.5

63.8

224

647

R5110, ,

SPAT

1.9

63.8

881

4823

D09

ICPC

Nausea

2.6

63.6

374

1449

Y94.0

ICD-10 Finland

Accident at home

3.3

63.6

243

741

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

4.0

63.5

185

470

GD1AD

NOMESCO Finland

Thorax CT examination

2.1

63.3

630

3070

N05AC02

ATC

thioridazine; oral

3.6

63.1

208

576

XA400

NOMESCO Finland

EEG

7.2

63.1

131

R4110

NOMESCO Finland

Physiotherapy

1.5

63.0

2215

15580

SPAT1211

SPAT

Application of soft bandage

1.9

62.8

821

4412

F51.0

ICD-10 Finland

Nonorganic insomnia

1.8

62.8

1167

6994

K07

ICPC

Swollen ankles/oedema

2.2

62.7

560

2615

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

3.5

62.5

218

627

JN4BD

NOMESCO Finland

Extensive body CT

1.8

62.4

984

5616

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

5.1

62.2

131

257

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.9

62.2

923

5168

A10AA01, ,

ATC

3.5

61.9

214

612

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.0

61.8

756

3970

D07AC01

ATC

betamethasone; topical

1.5

61.8

2981

22392

EBA00

NOMESCO Finland

Extraction of tooth

1.5

61.6

2762

20440

F10.4

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Withdrawal state with delirium

13.9

61.5

B01AF02

ATC

apixaban; oral

1.7

61.5

1365

8584

A02BC03

ATC

lansoprazole; oral

1.5

61.4

2466

17831

E000001, ,

ATC

1.6

61.3

1577

10298

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

6.0

61.3

109

183

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.7

61.3

1204

7326

N88

ICPC

Epilepsy

6.5

61.2

100

154

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.6

61.2

355

1366

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.9

61.0

889

4949

Z02.7

ICD-10 Finland

Issue of medical certificate

2.0

60.8

673

3412

C09CA03

ATC

valsartan; oral

1.9

60.6

887

4942

ZXE20

NOMESCO Finland

More than three and less than five hours

1.8

60.5

1117

6675

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

60.4

1680

11178

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.5

60.4

399

1635

Z71.4

ICD-10 Finland

Alcohol abuse counselling and surveillance

8.1

60.4

100

M79.6

ICD-10 Finland

Pain in limb

1.5

60.3

3487

27101

H3603, E103,

ICD-10 Finland

7.3

60.2

120

207

Kela drug reimbursment

Chronic arrhythmias

1.6

59.8

1614

10659

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.8

59.8

988

5715

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

3.7

59.8

189

509

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

2.6

59.7

345

1325

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

2.2

59.6

538

2522

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

3.7

59.6

191

519

SPAT1104

SPAT

Monitoring of emergency patient

2.1

59.5

630

3141

IAB10

NOMESCO Finland

Psychiatric consultation concerning substance abuse

18.7

59.1

AAE10

NOMESCO Finland

Transsphenoidal total or partial excision of intracranial lesion

9.8

58.9

Z49.1

ICD-10 Finland

Extracorporeal dialysis

4.6

58.8

140

305

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

8.1

58.6

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

4.0

58.5

166

414

OAB43, ,

SPAT

0.4

58.4

413

8752

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

58.3

3262

25146

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

5.2

58.3

120

231

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

3.4

58.2

214

637

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.9

58.2

280

977

D10

ICPC

Vomiting

2.5

58.1

370

1490

R06AE07

ATC

cetirizine; oral

1.5

58.0

3333

25817

S22.3

ICD-10 Finland

Fracture of rib

2.0

57.9

654

3337

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

5.8

57.9

106

183

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.6

57.3

349

1375

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

2.1

57.0

565

2747

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

5.5

56.9

110

200

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.1

56.6

567

2767

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

56.5

1561

10350

N06AX05

ATC

trazodone; oral

3.2

56.2

226

711

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

3.8

56.0

170

445

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

5.7

56.0

104

182

NF1AA

NOMESCO Finland

Hip X-ray examination

1.8

56.0

989

5828

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

4.2

56.0

152

367

SPAT1312

SPAT

General health counselling

1.5

55.9

2516

18552

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

2.1

55.6

551

2679

SPAT1307

SPAT

Psychosocial counselling and guidance

2.5

55.5

350

1402

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

55.3

1107

6757

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

3.5

55.1

193

557

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

54.9

3439

26981

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

5.2

54.9

114

221

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

3.1

54.9

232

752

N03AX23

ATC

brivaracetam; systemic

14.8

54.8

F34.1

ICD-10 Finland

Dysthymia

2.8

54.8

281

1015

F10.06

ICD-10 Finland

Alcohol-related acute intoxication with seizures

21.5

54.6

L89

ICD-10 Finland

Decubitus ulcer and pressure area

3.1

54.4

238

787

K86.3

ICD-10 Finland

Pseudocyst of pancreas

8.0

54.3

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

6.1

54.3

157

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

11.9

54.3

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.6

53.8

332

1317

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.4

53.7

390

1668

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

53.6

2853

21694

N06AB05

ATC

paroxetine; oral

2.2

53.4

460

2115

G40.89

ICD-10 Finland

Other epilepsy

7.8

53.4

IGV01

NOMESCO Finland

Psychiatric network contact

6.1

53.4

153

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

53.3

1511

10066

XW000

NOMESCO Finland

Bone marrow biopsy

2.4

53.3

392

1686

I20.09

ICD-10 Finland

Unstable angina

2.2

53.3

489

2307

IGY02, ,

SPAT

4.5

53.0

130

290

SPAT1125

SPAT

Stoma care and guidance

3.1

52.8

228

748

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.4

52.8

362

1508

E83.4

ICD-10 Finland

Disorders of magnesium metabolism

183.0

52.8

K70.9

ICD-10 Finland

Alcoholic liver disease, unspecified

9.0

52.8

H3600, E103,

ICD-10 Finland

6.3

52.7

142

ZXE00

NOMESCO Finland

One hour or less

1.4

52.5

2963

22756

XX3DW

NOMESCO Finland

Time consuming IT work

1.8

52.4

948

5618

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

5.2

52.3

107

205

U02

ICPC

Urinary frequency/urgency

1.6

52.0

1307

8453

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.8

52.0

274

1004

S72.0

ICD-10 Finland

Fracture of neck of femur

2.1

51.5

512

2490

N02BF02

ATC

pregabalin; oral

2.0

51.4

565

2852

A02BA02

ATC

ranitidine; systemic

1.5

51.3

1689

11633

SPAT1227

SPAT

Substance abuse rehabilitation

7.5

51.1

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

4.7

51.1

117

247

P74

ICPC

Anxiety disorder/anxiety state

2.7

51.1

283

1064

I50

ICD-10 Finland

Heart failure

2.3

51.1

387

1686

K59.1

ICD-10 Finland

Functional diarrhoea

2.1

51.0

512

2500

P76

ICPC

Depressive disorder

2.3

50.9

422

1910

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

4.9

50.8

112

229

F20

ICD-10 Finland

Schizophrenia

6.3

50.5

135

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.7

50.4

283

1071

A10BA02

ATC

metformin; oral

1.5

50.3

2328

17188

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.2

50.0

452

2119

P20

ICPC

Memory disturbance

1.6

49.9

1528

10348

N05AN01

ATC

lithium; oral

3.3

49.6

191

585

J96.0

ICD-10 Finland

Acute respiratory failure

3.7

49.6

158

428

Z49.0

ICD-10 Finland

Preparatory care for dialysis

5.1

49.4

105

208

G04CA02

ATC

tamsulosin; oral

1.5

49.4

1892

13445

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.9

49.3

615

3244

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.6

49.3

302

1193

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.8

49.3

852

4981

XF404

NOMESCO Finland

Ambulatory ECG

1.9

49.0

721

4013

U04

ICPC

Incontinence urine

1.9

48.9

640

3430

K56.7

ICD-10 Finland

Ileus, unspecified

3.2

48.9

199

631

F02.89*G40.9

ICD-10 Finland

Dementia in epilepsy

14.0

48.8

D07AA02

ATC

hydrocortisone; topical

1.7

48.7

1031

6373

SPAT1247

SPAT

Outpatient detoxication and monitoring

8.3

48.7

F05.8

ICD-10 Finland

Other delirium

4.4

48.7

121

273

WX002

NOMESCO Finland

Sedation and analgesia

1.5

48.6

1577

10808

N17

ICPC

Vertigo/dizziness

1.6

48.6

1170

7477

WVA20

NOMESCO Finland

Medicine administration

2.7

48.5

259

955

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

6.0

48.5

144

K85

ICPC

Elevated blood pressure

1.5

48.5

1576

10806

E89.00

ICD-10 Finland

Postirradiation hypothyroidism

11.6

48.5

G40.6

ICD-10 Finland

Grand mal seizures, unspecified (with or without petit mal)

7.9

48.4

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

3.8

48.4

147

385

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.0

48.4

583

3038

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.7

48.4

957

5810

R52.9

ICD-10 Finland

Pain, unspecified

1.8

48.3

838

4902

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

48.0

617

3287

G40.10

ICD-10 Finland

Simple partial seizures

5.4

48.0

173

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

2.4

47.9

350

1501

D12

ICPC

Constipation

2.3

47.8

383

1708

V03AB30, ,

ATC

5.5

47.7

167

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

6.8

47.7

108

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

4.7

47.6

110

234

K29.2

ICD-10 Finland

Alcoholic gastritis

11.6

47.6

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.7

47.6

1003

6192

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

47.5

1708

11961

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

3.1

47.5

203

662

D64.8

ICD-10 Finland

Other specified anaemias

3.0

47.5

211

704

U71

ICPC

Cystitis/urinary infection other

1.9

47.4

633

3415

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.2

47.3

417

1935

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

4.3

47.2

123

288

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.4

47.2

323

1345

N06AX12

ATC

bupropion; oral

2.3

47.1

387

1744

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

4.8

47.0

105

217

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

2.5

47.0

315

1299

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

5.7

47.0

152

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.8

46.8

243

883

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

2.5

46.8

310

1271

E10

ICD-10 Finland

Type 1 diabetes mellitus

3.9

46.7

136

346

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.1

46.5

486

2407

H02AB04

ATC

methylprednisolone; systemic

1.6

46.5

1187

7690

H36.00

ICD-10 Finland

Diabetic background retinopathy

4.1

46.5

130

321

R07.3

ICD-10 Finland

Other chest pain

1.8

46.5

836

4939

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.7

46.5

252

937

E83.50

ICD-10 Finland

Hypercalcemia

5.2

46.3

186

F10.52

ICD-10 Finland

Psychotic alcohol hallucination

14.4

46.3

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.1

46.3

460

2236

F10.02

ICD-10 Finland

Alcohol-related acute intoxication with other acute clinical complications

11.1

46.2

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.8

46.1

811

4761

N07BA03

ATC

varenicline; oral

2.4

46.0

326

1378

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.0

46.0

516

2622

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

3.5

46.0

159

455

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

6.9

46.0

103

D01

ICPC

Abdominal pain/cramps general

1.7

46.0

895

5405

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

46.0

2306

17234

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.5

45.9

302

1234

C09DA06

ATC

candesartan and diuretics; oral

1.9

45.9

662

3660

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

4.8

45.8

103

214

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.2

45.8

180

559

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.6

45.7

1094

6974

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

8.6

45.6

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.3

45.6

371

1666

D11

ICPC

Diarrhoea

1.7

45.5

821

4853

M48.0

ICD-10 Finland

Spinal stenosis

1.6

45.4

1168

7576

U01

ICPC

Dysuria/painful urination

1.8

45.3

681

3813

G62.1

ICD-10 Finland

Alcoholic polyneuropathy

7.6

45.3

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.0

45.3

203

681

M05BA04

ATC

alendronic acid; oral

1.7

45.3

1006

6292

K02.1

ICD-10 Finland

Caries of dentine

1.4

45.3

4120

34076

XA800

NOMESCO Finland

Neuropsychological investigation

2.5

45.2

280

1112

R4190

NOMESCO Finland

Nutritional therapy

2.5

45.2

285

1142

IGY02

NOMESCO Finland

Psychiatric monitoring contact

3.0

45.1

198

656

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.7

45.1

870

5239

R04.0

ICD-10 Finland

Epistaxis

1.8

45.1

704

3988

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.4

45.1

326

1391

E23.2

ICD-10 Finland

Diabetes insipidus

11.8

45.0

A04AA01

ATC

ondansetron; systemic, rectal

1.8

44.9

716

4082

Z00.0

ICD-10 Finland

General medical examination

1.5

44.8

1569

10912

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.0

44.8

480

2399

R95

ICPC

Chron obstructive pulmonary disease

2.5

44.7

296

1214

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.4

44.6

306

1275

K90

ICPC

Stroke/cerebrovascular accident

2.5

44.6

277

1102

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.9

44.5

574

3061

X58

ICD-10 Finland

Exposure to other specified factors

1.6

44.3

1067

6808

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.6

44.2

1161

7566

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

8.5

44.2

C09CA06

ATC

candesartan; oral

1.5

44.2

1924

13980

P01AB01

ATC

metronidazole; oral, rectal

1.4

44.2

2940

23065

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

44.2

1589

11109

Z00.8

ICD-10 Finland

Other general examinations

1.9

44.2

628

3455

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.9

44.0

550

2901

A07AA02

ATC

nystatin; oral

1.9

44.0

570

3043

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

6.2

43.9

121

B03BA03

ATC

hydroxocobalamin; parenteral

1.9

43.8

568

3033

I25.2

ICD-10 Finland

Old myocardial infarction

2.0

43.8

525

2730

N06AX22

ATC

agomelatine; oral

3.3

43.7

163

490

R39.1

ICD-10 Finland

Other difficulties with micturition

2.5

43.6

291

1197

N03AB02

ATC

phenytoin; systemic

3.6

43.6

147

414

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.8

43.5

218

778

F10.01

ICD-10 Finland

Alcohol-related acute intoxication with permanent or other somatic damage

5.8

43.5

139

A10BH05

ATC

linagliptin; oral

2.0

43.4

470

2357

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

3.7

43.4

139

378

SPAT1304

SPAT

Counselling and guidance related to ageing

1.7

43.4

825

4947

F41.09

ICD-10 Finland

UNS Panic Syndrome

3.1

43.4

183

593

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

43.3

1587

11135

A10AE06

ATC

insulin degludec; parenteral

2.6

43.3

254

983

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.5

43.2

1867

13540

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.2

43.1

391

1834

N02BF01

ATC

gabapentin; oral

1.7

43.1

822

4934

B01AA03

ATC

warfarin; systemic

1.5

42.7

1767

12703

L76

ICPC

Fracture: other

2.3

42.6

344

1539

R35

ICD-10 Finland

Polyuria

1.9

42.5

611

3372

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.0

42.4

504

2612

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.9

42.4

202

701

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

6.1

42.4

122

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.9

42.4

546

2909

F32

ICD-10 Finland

Depressive episode

2.2

42.3

350

1582

J01DA01

ATC

[U] cefalexin

1.4

42.1

4793

40872

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.2

42.1

360

1650

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

5.6

42.0

140

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.5

42.0

1736

12472

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

4.4

41.8

104

235

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3006504) Eosinophils/Leukocytes in Blood

5208

33281

2.37

323.31

8.7

6.3

2.51

2.84

21.30

4946

30799

(42870588) Differential panel, method unspecified - Blood

4200

24558

2.34

320.20

7.7

6.2

—

(3022096) Basophils/Leukocytes in Blood

5185

33280

2.34

315.63

8.8

6.4

0.63

0.67

7.18

4937

30781

(3002030) Lymphocytes/Leukocytes in Blood

5259

33968

2.35

315.29

8.8

6.3

23.23

26.90

98.54

5035

31818

(3028626) Oxygen [Partial pressure] in Capillary blood

773

1744

4.73

314.56

5.4

2.9

7.96

8.05

kpa

0.76

754

1705

(1616796) Gas panel - Central venous blood

718

1537

4.96

311.22

4.8

3.6

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1366

4138

3.70

307.65

5.4

3.3

2.20

2.04

mmol/l

0.70

1036

3123

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

4482

25434

2.54

307.65

4.2

3.1

2190.82

1488.44

ng/l

13.44

3987

21883

(3021960) Folate [Moles/volume] in Serum or Plasma

4148

23268

2.46

307.65

2.1

1.7

20.33

20.53

nmol/l

0.35

3636

19189

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

2244

9042

2.97

307.65

4.0

4.4

244.55

247.67

u/l

0.30

2114

8537

(3026782) Osmolality of Urine

4814

14469

6.12

307.65

3.6

2.9

391.18

535.55

mosm/kgh2o

307.65

4208

12592

(3023368) Bacteria identified in Blood by Culture

4801

22063

3.57

307.65

6.0

4.1

—

(3003396) Base excess in Arterial blood by calculation

2426

8757

3.42

307.65

11.2

6.6

1.02

1.12

mmol/l

0.47

2024

7172

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2414

9884

2.97

307.65

2.2

1.8

—

(3002582) Erythrocytes [#/volume] in Urine

4321

24989

2.41

307.65

5.5

3.3

59.02

89.41

e6/l

1.22

3710

19163

(3020779) Urea [Moles/volume] in Serum or Plasma

2006

6410

3.73

307.65

9.6

5.7

10.02

10.18

mmol/l

0.37

1919

6074

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

3277

13395

3.28

307.65

2.4

1.9

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1494

4567

3.71

307.65

11.2

7.2

24.41

24.98

mmol/l

5.28

1474

4525

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1336

4232

3.52

307.65

5.9

3.3

24.06

24.36

mmol/l

2.22

1315

4184

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1565

4931

3.62

307.65

5.7

3.4

5.11

5.19

kpa

2.31

1500

4674

(3006315) Basophils [#/volume] in Blood

5679

36472

2.55

307.65

8.3

6.0

0.04

e9/l

0.19

5043

31011

(3002173) Hemoglobin [Mass/volume] in Arterial blood

2001

7169

3.29

307.65

12.4

7.4

116.47

120.06

g/l

11.86

1966

6982

(3014111) Lactate [Moles/volume] in Serum or Plasma

2071

6643

3.74

307.65

10.7

6.4

1.39

1.38

mmol/l

0.13

2021

6504

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1997

7319

3.21

307.65

2.8

2.2

0.19

0.20

g/l

12.08

1827

6812

(3009343) pH of Capillary blood

1514

4786

3.59

307.65

5.7

3.4

7.42

0.29

1326

3893

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2880

9301

4.09

307.65

7.8

4.7

1.04

1.03

mmol/l

0.90

2726

8511

(3019977) pH of Arterial blood

2443

8839

3.42

307.65

11.4

6.7

7.42

1.20

1473

4988

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

5207

30001

2.79

307.65

6.8

3.7

53.74

70.56

ng/l

0.40

4492

22601

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2815

10875

3.31

307.65

3.4

2.3

20.47

21.60

3.75

2590

9927

(3013115) Eosinophils [#/volume] in Blood

5764

37514

2.54

307.65

8.7

6.2

0.18

0.19

e9/l

6.81

5165

32426

(3004119) Hemoglobin [Mass/volume] in Venous blood

1441

4685

3.46

307.65

4.9

2.8

122.12

127.94

g/l

18.46

1402

4557

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

4635

23180

3.09

307.65

3.3

2.1

351.16

215.30

u/l

3.13

4443

21647

(3026008) Bacteria identified in Urine by Culture

4794

25674

2.89

307.65

5.1

3.5

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

6576

39747

3.59

307.65

13.8

6.2

1.19

1.22

mmol/l

121.20

5650

33722

(3019198) Lymphocytes [#/volume] in Blood

5724

37177

2.53

307.65

8.4

6.1

1.72

1.89

e9/l

4.65

5151

32418

(3036481) Cortisol [Moles/volume] in Serum or Plasma

3665

5764

10.14

307.65

2.4

2.3

421.27

375.74

nmol/l

20.38

3417

5272

(3023183) Ammonium ion [Moles/volume] in Plasma

921

1359

7.40

307.65

3.3

2.4

33.33

33.97

umol/l

0.30

840

1200

(3027801) Oxygen [Partial pressure] in Arterial blood

2432

8871

3.38

307.65

11.3

6.6

11.52

12.28

kpa

11.32

2341

8487

(3027945) Reticulocytes/Erythrocytes in Blood

2396

9263

3.16

307.65

2.7

2.4

2.02

1.77

18.30

2111

8143

(3013826) Glucose [Moles/volume] in Serum or Plasma

6872

43900

3.59

307.65

10.8

4.5

6.98

6.72

mmol/l

17.11

6727

41593

(3024354) Oxygen [Partial pressure] in Venous blood

1987

6447

3.66

307.65

5.4

2.7

4.50

4.42

kpa

0.85

1919

6289

(3001604) Monocytes [#/volume] in Blood

5653

36311

2.54

307.65

8.3

6.0

0.67

0.60

e9/l

19.14

5023

30848

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2429

10736

2.72

307.65

2.4

2.0

30.04

29.72

1.49

2361

10413

(3023520) Reticulocytes [#/volume] in Blood

1967

7254

3.18

307.65

2.7

2.6

72.58

67.68

e9/l

6.10

1534

5431

(3016502) Oxygen saturation in Arterial blood

2219

7855

3.42

307.65

11.5

6.9

95.30

95.46

0.52

2153

7557

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

4318

20194

3.22

307.65

3.1

2.3

2.98

2.99

mg/l

0.01

3780

17283

(3001122) Ferritin [Mass/volume] in Serum or Plasma

5095

31355

2.47

307.65

4.3

2.9

184.55

142.79

ug/l

7.96

4670

28621

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2987

11799

3.30

307.65

3.3

2.3

2.22

2.30

g/l

10.29

2748

10720

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2431

8873

3.38

307.65

11.4

6.6

4.92

5.11

kpa

14.64

2347

8496

(3022948) Iron [Moles/volume] in Serum or Plasma

3133

12706

3.25

307.65

3.4

2.3

11.03

12.40

umol/l

21.89

2882

11628

(3003181) Sodium [Moles/volume] in Urine

3799

838

78.78

307.65

1.6

1.2

55.43

66.02

mmol/l

10.41

2990

646

(3032080) INR in Blood by Coagulation assay

6235

36632

3.40

307.65

19.0

16.6

1.26

1.32

inr

14.29

5481

30560

(3024561) Albumin [Mass/volume] in Serum or Plasma

5964

35003

3.17

307.65

7.8

4.6

33.10

35.13

g/l

119.65

5645

32404

(3018418) pH of Serum or Plasma

4241

23496

2.54

307.65

6.5

3.7

7.40

0.62

3370

16896

(3031040) Bacteria [#/volume] in Urine by Automated count

6959

49621

2.92

307.65

8.9

5.0

1669.14

2670.35

e6/l

0.79

122

640

(3002032) Base excess in Venous blood by calculation

2299

7356

3.85

307.65

5.9

3.2

1.70

1.93

mmol/l

1.76

2007

6431

(3012544) pH of Venous blood

2345

7642

3.79

307.65

5.9

3.2

7.38

1.41

1453

4347

(3019309) Folate [Moles/volume] in Red Blood Cells

3022

15036

2.52

307.65

2.1

1.7

1351.40

1167.40

nmol/l

17.42

2303

11165

(3000850) Epithelial cells [#/volume] in Urine

3415

17624

2.51

307.65

4.2

2.6

5.70

5.68

e6/l

0.03

3243

15925

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

6048

35594

3.23

307.65

13.2

5.7

1.19

1.21

mmol/l

134.52

5727

32358

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2244

9147

2.93

307.65

2.3

1.8

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

4716

23935

3.07

307.65

4.3

2.5

57.40

62.85

u/l

2.50

4441

21939

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

6502

39503

3.47

307.65

10.1

6.4

12.03

12.05

umol/l

0.03

6253

37484

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1666

5690

3.35

307.65

2.0

1.6

—

(3019069) Monocytes/Leukocytes in Blood

5223

33373

2.37

307.65

8.9

6.4

9.37

9.03

12.52

4974

30890

(3000991) Gas panel - Venous blood

1885

6269

3.53

307.65

12.9

7.4

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

3636

11962

4.45

307.65

4.8

3.0

0.77

0.82

mmol/l

79.22

3438

11118

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

4720

27547

2.52

307.65

5.5

3.3

—

2.31

—

(3008295) Osmolality of Serum or Plasma

1643

573

34.80

307.65

1.4

1.3

263.91

284.17

mosm/kgh2o

76.26

1309

403

(3015235) Bicarbonate [Moles/volume] in Capillary blood

957

2492

4.15

307.65

4.1

2.7

24.79

25.13

mmol/l

1.41

935

2447

(3016038) Potassium [Moles/volume] in Urine

1334

288

54.04

307.65

1.2

1.1

31.38

37.10

mmol/l

3.82

1168

235

(3021447) Carbon dioxide [Partial pressure] in Venous blood

2364

7587

3.87

307.65

6.0

3.2

5.68

5.83

kpa

9.01

2284

7414

(3013650) Neutrophils [#/volume] in Blood by Automated count

6109

41291

2.55

307.65

13.8

9.4

4.69

4.19

e9/l

38.19

5511

35595

(3027273) Bicarbonate [Moles/volume] in Venous blood

1143

3492

3.58

306.83

5.4

2.9

25.03

25.29

mmol/l

1.45

1109

3394

(3018010) Neutrophils/Leukocytes in Blood

5135

33209

2.29

301.40

8.5

6.2

60.88

57.96

50.41

4964

31423

(3018095) Leukocytes [#/volume] in Urine

4533

27872

2.27

300.32

6.5

3.8

111.59

122.88

e6/l

0.39

3747

19883

(3030467) Casts [#/volume] in Urine by Automated count

3790

21677

2.30

298.53

5.2

3.2

0.49

0.46

e6/l

0.22

3198

16104

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1213

3936

3.39

295.85

1.7

1.4

—

(3019060) Gas panel - Arterial blood

1369

4792

3.17

294.63

7.0

4.4

—

(40767503) Oxygen content in Capillary blood by calculation

692

1514

4.84

291.85

3.6

2.4

15.44

16.38

11.58

676

1480

(3021901) Oxygen saturation in Capillary blood

678

1476

4.86

287.58

3.9

2.7

89.22

89.58

0.63

661

1436

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

957

2720

3.80

285.24

2.3

2.1

491.33

621.70

ug/l

0.53

912

2562

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1206

3989

3.32

284.62

6.5

3.4

48.38

47.02

1.03

1185

3935

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1060

3240

3.56

283.36

2.2

1.8

1.92

2.51

ug/l

0.89

947

2812

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1596

6243

2.88

281.06

2.5

1.7

1.88

1.48

35.76

1326

5352

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1111

3520

3.44

280.74

1.7

1.58

1.56

g/l

0.17

974

2989

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1345

4830

3.08

275.90

11.0

6.3

24.40

24.72

mmol/l

2.00

1302

4618

(3020630) Protein [Mass/volume] in Serum or Plasma

1671

6766

2.79

275.22

2.8

2.5

64.70

66.20

g/l

10.30

1521

6043

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

7365

56965

2.80

271.81

14.2

8.0

87.83

80.87

u/l

18.81

7128

53542

(3014007) Fractional oxyhemoglobin in Arterial blood

1371

5023

3.03

271.22

14.7

8.2

93.59

93.89

0.96

1360

5009

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1331

4816

3.05

269.03

14.9

8.4

0.66

0.03

1320

4789

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1364

5009

3.02

268.56

14.6

8.1

1.40

1.34

1.54

1353

4983

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1238

4354

3.12

262.53

13.7

8.2

24.24

24.44

mmol/l

1.08

1210

4231

(3037467) Urinalysis macro (dipstick) panel - Urine

6762

50569

2.44

262.03

8.1

4.8

1477.40

2.29

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

866

2434

3.81

261.59

1.5

1.3

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3711

22014

2.17

256.52

4.6

3.2

42.56

35.05

u/l

1.90

3510

20527

(3042936) Bacteria identified in Isolate by Culture

2191

10511

2.42

251.77

2.6

2.0

—

(36304419) Bacteria [Presence] in Urine

3505

20456

2.17

251.30

5.1

3.2

8.39

137.40

estimate

0.57

113

(3010421) pH of Blood

843

2407

3.74

248.46

5.3

3.3

7.41

0.18

825

2372

(3009466) Valproate [Moles/volume] in Serum or Plasma

477

867

5.71

247.66

5.9

4.8

382.10

347.21

umol/l

4.76

426

729

(3020891) Body temperature

1125

3902

3.13

243.37

8.9

3.9

36.93

36.91

°c

1.72

1107

3865

(3028271) Lactate [Moles/volume] in Capillary blood

547

1150

4.97

241.13

2.5

1.7

1.70

1.68

mmol/l

0.16

532

1113

(3021601) Nitrite [Presence] in Urine by Test strip

5531

38910

2.12

236.11

6.8

4.2

0.00

estimate

2.33

1610

8174

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

5126

35084

2.09

235.22

2.8

2.1

94.04

95.76

pmol/l

1.58

2929

18089

(3035350) Ketones [Presence] in Urine by Test strip

5574

39420

2.11

233.32

6.8

4.2

6.68

2.24

estimate

1.12

1633

8516

(3013290) Carbon dioxide [Partial pressure] in Blood

628

1523

4.33

231.70

5.2

3.8

5.00

5.02

kpa

0.22

609

1482

(3012501) Base excess in Blood by calculation

627

1522

4.32

231.04

5.2

3.8

3.10

2.61

mmol/l

2.68

452

1045

(3020191) Ethanol [Moles/volume] in Serum or Plasma

319

410

7.97

230.26

2.0

1.2

1.31

1.26

promille

0.16

249

320

(3027315) Oxygen [Partial pressure] in Blood

628

1536

4.29

229.09

5.2

3.8

8.50

kpa

0.01

609

1495

(3015377) Calcium [Moles/volume] in Serum or Plasma

4269

27577

2.05

226.47

4.2

3.4

2.33

2.36

mmol/l

44.33

3890

24698

(3009261) Glucose [Presence] in Urine by Test strip

5575

39743

2.08

224.10

6.9

4.2

0.07

0.42

estimate

0.95

1561

8081

(44816559) Phosphatidylethanol [Mass/volume] in Blood

743

2114

3.72

219.36

2.3

1.6

0.42

0.31

mg/l

4.76

430

943

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4887

33616

2.00

211.90

3.2

2.3

77.91

80.14

nmol/l

5.63

4428

29553

(3044640) Blood type and Crossmatch panel - Blood

3804

24073

2.00

208.43

3.6

2.5

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

5898

43501

2.06

208.24

6.0

3.2

84.31

50.69

u/l

43.55

5525

39960

(3004588) Protein electrophoresis panel - Serum or Plasma

1328

5482

2.65

206.05

2.6

2.3

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1202

4754

2.75

202.76

2.1

1.7

—

(3007853) Bacteria identified in Skin by Aerobe culture

1808

8679

2.34

202.23

2.2

1.7

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1244

5022

2.70

201.51

3.3

3.0

10.87

10.57

g/l

1.10

1149

4596

(3029937) Albumin [Presence] in Urine by Test strip

3648

23021

1.98

198.86

6.9

4.4

0.00

estimate

0.47

1475

7498

(3018405) Lactate [Moles/volume] in Arterial blood

813

2608

3.31

198.79

6.9

3.7

1.34

1.37

mmol/l

0.24

793

2579

(3011985) Renin [Units/volume] in Plasma

407

787

5.33

197.05

2.3

1.3

80.73

55.67

mu/l

0.49

362

700

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1078

4086

2.84

196.90

14.7

9.0

15.37

15.87

7.46

1052

3908

(3017181) Myelocytes/Leukocytes in Blood

1501

6740

2.46

194.39

5.2

4.1

0.99

0.97

0.12

628

2078

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1461

6493

2.48

193.43

6.0

3.3

1.21

1.23

mmol/l

19.19

1326

5427

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2902

17034

2.03

193.10

2.0

1.7

12399689.08

31194976.59

pmol/l

1.79

2355

13746

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2670

15283

2.06

189.84

2.0

1.7

1.62

1.38

mg/l

1.70

2201

11850

(3015736) pH of Urine

4531

31252

1.91

184.93

5.6

3.7

6.54

6.28

40.92

2528

17112

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1676

8078

2.31

183.94

5.9

3.4

—

(3002179) Metamyelocytes/Leukocytes in Blood

1429

6457

2.43

181.55

5.0

4.0

0.72

0.74

0.16

604

1991

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4804

33928

1.90

180.61

3.9

2.8

—

estimate

—

(3021440) Promyelocytes/Leukocytes in Blood

1414

6428

2.41

176.89

5.2

4.1

0.13

0.10

0.90

543

1786

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1652

8064

2.27

175.09

3.9

2.6

10.96

9.58

umol/l

1.12

1439

7081

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

903

3321

2.89

173.47

7.5

4.6

1.63

1.59

0.47

867

3119

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

648

1963

3.46

172.96

4.9

3.0

1.80

1.55

mg/l

8.30

591

1733

(3028026) IgM [Mass/volume] in Serum or Plasma

998

3885

2.75

172.16

2.0

1.27

1.45

g/l

1.44

918

3509

(3022806) Fractional oxyhemoglobin in Capillary blood

403

879

4.72

169.28

2.4

1.6

89.07

89.46

0.53

394

861

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2493

14459

1.99

166.99

6.1

3.7

247.56

444.69

ng/l

1.42

2163

11944

(3022313) Gas panel - Capillary blood

905

3421

2.81

164.85

6.4

3.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

617

1875

3.44

163.68

1.7

1.5

—

(40760892) CBC W Ordered Manual Differential panel - Blood

2566

15157

1.96

162.17

7.0

4.7

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

4269

29688

1.83

161.74

6.9

4.2

1.67

0.71

estimate

0.65

1329

6681

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1273

5737

2.41

161.30

5.1

3.1

103.47

86.64

ng/l

5.27

1053

4779

(3025159) Blasts/Leukocytes in Blood

1385

6481

2.33

161.04

5.6

4.3

0.18

0.35

0.67

508

1697

(3006184) Hemoglobin [Mass/volume] in Capillary blood

589

1770

3.47

158.92

3.1

2.2

124.34

128.08

g/l

3.08

506

1329

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1431

6863

2.28

156.68

3.3

2.3

6.27

7.00

ug/l

0.86

1206

5897

(3034860) Kappa light chains.free [Mass/volume] in Serum

756

2681

2.97

154.56

3.1

3.2

63.52

62.23

mg/l

0.03

600

2258

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

754

2680

2.96

153.49

3.1

3.2

42.78

45.00

mg/l

0.16

596

2264

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2927

18450

1.86

149.20

3.5

2.4

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

6688

54197

1.95

147.85

5.9

4.3

15.71

15.01

pmol/l

70.44

6193

48644

(3024928) Oxygen saturation in Venous blood

564

1729

3.39

147.27

3.5

2.6

61.32

60.25

0.48

538

1673

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

606

1946

3.24

146.77

1.7

1.6

—

(3033658) Prothrombin time (PT) actual/Normal

2865

18025

1.86

146.30

7.0

3.9

85.25

86.90

2.77

2803

17629

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1296

6157

2.28

144.24

3.5

2.3

0.44

0.53

e6/l

0.77

1245

5924

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

305

606

5.14

142.88

1.5

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

679

2370

3.00

142.48

3.0

3.1

4.47

9.68

ratio

0.50

395

1390

(3000012) Reticulocyte production index

434

1144

3.91

141.97

2.0

2.2

0.91

0.89

0.16

326

744

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

583

1883

3.22

139.72

1.5

1.6

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

628

2124

3.08

139.18

2.1

1.6

—

(3021589) Normoblasts [#/volume] in Blood

4377

31620

1.75

137.27

23.5

11.4

0.00

e9/l

0.46

3761

25849

(3007930) Methemoglobin/Hemoglobin.total in Blood

788

3044

2.72

136.75

7.6

4.8

0.83

0.87

2.04

753

2847

(3007164) IgA [Mass/volume] in Serum or Plasma

2143

12539

1.92

135.26

1.7

1.5

3.00

2.54

g/l

9.62

1384

7232

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

472

1372

3.55

133.68

7.6

4.5

475.25

1761.20

iu/ml

0.55

187

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

6596

53860

1.88

133.58

6.3

4.5

18.28

13.36

mm/h

80.25

6177

49610

(3043409) Potassium [Moles/volume] in Arterial blood

640

2239

2.98

133.54

8.0

3.9

3.85

3.88

mmol/l

0.71

634

2224

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

331

752

4.50

131.93

1.3

429.39

281.37

pmol/l

0.90

283

643

(3017143) Hepatitis C virus Ab [Presence] in Serum

1236

5980

2.22

130.71

1.9

1.5

—

(3047181) Lactate [Moles/volume] in Blood

610

2126

2.98

128.02

7.7

5.4

1.34

1.32

mmol/l

0.13

547

1865

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

180

236

7.70

127.49

2.7

2.3

58.04

52.62

umol/l

0.89

153

197

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

450

1341

3.46

122.52

1.7

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

695

2708

2.68

118.05

6.8

3.5

24.73

25.07

mmol/l

1.85

640

2456

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1989

11808

1.87

117.70

4.9

3.1

2.68

2.78

e6/l

0.16

1154

5807

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1366

7174

2.05

115.71

1.9

1.5

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

176

253

7.02

114.85

1.9

2.0

97.98

134.18

umol/l

0.70

103

138

(46235355) HIV 1 and 2 tests - Meaningful Use set

1465

7932

2.00

113.83

2.0

1.6

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

371

1023

3.71

113.51

1.9

2.2

32.67

32.29

0.84

366

1016

(3000570) Elastase.pancreatic [Mass/mass] in Stool

610

2267

2.79

113.46

1.5

1.4

246.04

271.85

ug/g

2.13

366

1359

(3041096) Erythrocytes [Presence] in Urine by Automated

2973

20059

1.71

112.77

6.2

3.6

0.67

0.42

estimate

0.31

1301

6448

(3026250) Tacrolimus [Mass/volume] in Blood

154

195

7.96

112.34

48.9

34.6

6.99

7.16

ug/l

0.35

141

170

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2165

13359

1.81

112.25

4.6

3.0

1.44

1.43

e6/l

0.03

1343

7363

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2577

16763

1.74

111.23

3.4

3.1

2.46

mmol/l

0.21

2308

15036

(3002079) Sodium [Moles/time] in 24 hour Urine

149

186

8.07

109.99

1.1

1.3

138.71

160.27

mmol/24h

1.84

149

186

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

708

2883

2.56

109.73

2.8

—

(40768797) Stomach Pathology biopsy report

1737

10072

1.89

109.68

1.4

1.2

—

(40761536) Microorganisms panel - Urine sediment

1189

6046

2.10

109.42

7.2

4.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

497

1686

3.04

109.08

1.6

1.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

756

3199

2.47

107.95

2.4

1.9

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

708

2918

2.53

106.91

2.3

1.8

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

434

1377

3.24

106.69

1.3

4.06

3.73

mmol/l

3.18

407

1300

(3019230) Fractional oxyhemoglobin in Venous blood

459

1514

3.12

105.70

3.6

2.4

60.39

60.97

0.20

454

1508

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

7854

69584

2.18

105.15

40.1

16.4

26.12

26.19

mg/l

0.07

7490

57805

(3037522) Nuclear Ab [Titer] in Serum

1572

8955

1.90

104.27

1.4

1.3

560.70

532.29

titre

0.24

399

2050

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

469

1584

3.05

103.66

1.4

636.60

576.64

mg/l

0.41

442

1503

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

441

1445

3.14

102.67

1.6

1.4

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1260

6689

2.01

102.63

4.1

2.4

52.73

46.81

u/l

0.11

1062

5644

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

343

960

3.65

102.58

1.7

1.5

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2295

14733

1.74

102.25

1.4

1.3

1.65

1.90

u/ml

0.39

656

3763

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

441

1453

3.12

101.70

1.6

1.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

313

830

3.84

101.26

5.3

12.9

7.48

7.20

mmol/l

0.54

272

674

(3007566) Smooth muscle Ab [Titer] in Serum

492

1731

2.93

101.09

1.3

1.2

174.92

156.49

titre

0.13

151

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

4647

35825

1.61

100.39

3.0

2.5

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

148

204

7.30

100.31

3.0

2.9

28.44

29.03

umol/l

0.20

103

163

(3044290) Cell count panel - Cerebral spinal fluid

398

1252

3.26

99.15

1.6

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

334

954

3.57

96.86

1.7

1.5

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

414

1360

3.12

95.90

1.6

1.5

761.88

1426.51

e6/l

1.16

357

1096

(3034770) Mitochondria Ab [Titer] in Serum

481

1720

2.88

95.86

1.2

857.50

856.55

titre

0.00

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

353

1057

3.41

95.17

4.3

2.4

25507.60

1150.01

u/ml

0.58

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

409

1341

3.12

95.04

1.5

22.94

37.30

e6/l

0.51

327

1025

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

617

2519

2.54

94.74

3.4

2.7

0.32

0.36

iu/ml

1.57

361

1382

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

378

1192

3.24

93.75

1.6

1.4

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

218

471

4.68

92.38

1.5

1.3

2.39

2.22

mmol/l

0.47

201

438

(3009508) Creatinine [Moles/volume] in Urine

3511

25655

1.60

92.24

4.2

3.2

5.28

7.18

mmol/l

166.07

2936

21025

(3013512) EKG study

3785

28177

1.59

91.68

5.5

3.6

0.67

0.71

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

687

3019

2.36

89.69

1.4

1.6

5.83

21.00

iu/ml

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

151

241

6.31

89.21

18.3

18.6

1431.73

1342.61

nmol/l

0.65

144

231

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

721

3256

2.30

88.34

2.7

2.2

7.48

7.41

g/l

0.48

648

2891

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

719

3246

2.30

88.15

2.7

2.2

3.62

3.70

g/l

0.49

648

2884

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

803

3797

2.21

88.05

3.3

3.2

4.08

4.44

pmol/l

17.25

705

3324

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

719

3253

2.30

87.69

2.7

2.2

4.11

4.23

g/l

3.22

647

2892

(3037756) Immunofixation for Serum or Plasma

450

1630

2.83

87.46

1.5

1.6

—

(3020682) Albumin/Creatinine [Ratio] in Urine

3455

25376

1.58

87.39

5.0

3.8

18.97

6.68

mg/mmol

20.57

2259

14983

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

456

1680

2.79

85.82

1.7

1.5

—

(3028707) Methadone [Presence] in Urine by Screen method

216

492

4.44

85.70

3.9

2.7

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

184

369

5.03

85.19

2.4

2.3

15.84

17.46

nmol/l

1.20

169

347

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

143

227

6.34

84.94

13.7

14.4

754.43

793.01

nmol/l

0.38

137

215

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1182

6546

1.91

83.88

4.0

2.9

259.59

222.90

ng/l

1.77

1100

5986

(40758558) Short blood count panel - Blood

3062

22060

1.58

83.02

10.3

6.1

—

(3000494) Fungus identified in Specimen by Culture

1466

8727

1.80

82.54

1.7

1.5

—

(3017569) Oxygen content in Arterial blood

193

416

4.68

82.02

2.2

15.27

16.03

2.26

193

416

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

7343

64792

1.78

81.75

7.4

5.3

1.99

2.00

mu/l

0.25

6871

58554

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

523

2118

2.54

81.44

1.5

1.3

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1484

8900

1.79

81.37

3.8

4.3

12.94

23.63

ug/l

2.85

1253

7378

(3026493) Urate [Moles/volume] in Serum or Plasma

2707

19030

1.60

81.06

3.6

2.6

346.62

345.47

umol/l

0.18

2307

16306

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

673

3061

2.28

80.86

2.7

2.2

2.97

2.92

g/l

0.51

599

2700

(3017732) Neutrophils [#/volume] in Blood

1510

9120

1.78

80.77

4.4

3.1

5.31

4.66

e9/l

1.23

1251

7675

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

239

625

3.87

78.81

1.6

1.5

—

(3025941) Bacteria identified in Stool by Culture

729

3470

2.18

78.30

1.5

1.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

176

376

4.72

75.62

2.3

1.9

8.10

8.12

mmol/l

0.02

176

376

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

466

1858

2.57

74.86

2.7

2.4

3.56

g/l

0.01

442

1765

(3012516) Albumin [Mass/volume] in Urine

3334

24912

1.53

74.55

4.2

3.2

79.48

38.21

mg/l

14.46

2243

15229

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

580

2565

2.33

74.28

1.3

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

148

281

5.30

72.93

2.5

1.8

1400.49

2450.87

e6/l

0.24

109

195

(3026692) Albumin [Mass/volume] in Peritoneal fluid

121

190

6.39

72.66

1.7

1.4

11.52

14.05

g/l

1.81

145

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

608

2781

2.26

71.86

2.7

2.2

0.91

1.01

g/l

0.18

495

2309

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

613

2814

2.25

71.82

2.6

2.1

10.13

10.33

g/l

0.42

528

2416

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

327

1123

2.96

69.94

1.9

1.3

—

(3003434) Protein [Mass/volume] in Pleural fluid

346

1227

2.87

69.81

1.6

1.4

30.97

32.31

g/l

1.03

307

1108

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

11.04

69.40

5.4

6928.00

503.40

iu/ml

—

(3045414) Leukocytes [Presence] in Urine

1283

7699

1.77

69.21

2.9

2.1

0.02

0.01

estimate

0.04

257

1347

(40768446) Kidney Pathology biopsy report

112

171

6.57

69.10

2.1

1.5

—

(3037121) Protein [Mass/volume] in Urine

566

2561

2.27

68.58

4.2

3.0

1432.60

478.54

mg/l

1.21

299

990

(3042733) HLA Ab [Presence] in Serum

128

7.59

68.32

5.0

4.5

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

2563

18352

1.55

68.27

6.3

4.1

0.45

0.34

0.16

263

(3016650) Hepatitis A virus Ab [Presence] in Serum

290

946

3.11

67.85

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

781

4020

2.02

67.84

1.5

1.4

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

457

1903

2.46

66.86

1.9

1.6

0.22

0.23

g/l

1.19

432

1809

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

464

1960

2.42

65.78

1.9

1.6

1.12

1.18

g/l

3.98

442

1866

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

321

1134

2.88

65.21

1.9

1.3

28.83

16.26

u/ml

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

151

325

4.67

64.32

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

297

1013

2.98

64.29

6.1

6.3

12.80

12.16

mg/l

1.38

275

927

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

289

977

3.00

63.55

1.7

1.2

264.87

283.61

u/ml

0.50

190

576

(3019550) Sodium [Moles/volume] in Serum or Plasma

7915

72518

1.88

63.43

54.1

19.4

134.71

139.73

mmol/l

307.65

7813

70884

(3036489) Thrombin time

512

2298

2.29

63.15

2.3

2.0

20.94

21.25

0.43

473

2034

(3020876) Protein [Mass/time] in 24 hour Urine

249

774

3.26

63.14

2.3

2.2

1.32

1.10

g/24h

0.61

151

410

(3004809) Band form neutrophils/Leukocytes in Blood

356

1351

2.68

63.09

3.8

3.7

1.51

1.55

0.08

324

1199

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

306

1076

2.89

62.69

1.6

1.2

22.30

40.86

u/ml

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

290

991

2.97

62.56

2.0

1.3

149.89

153.59

au/ml

0.17

294

(3023103) Potassium [Moles/volume] in Serum or Plasma

7915

72654

1.85

61.07

52.7

19.6

4.04

3.99

mmol/l

48.33

7814

70891

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

125

240

5.23

60.86

2.5

1.6

8642.70

19768.29

e6/l

0.60

135

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

269

901

3.02

60.12

1.3

0.65

4.34

nmol/l

0.92

254

866

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

188

504

3.76

59.86

2.3

2.4

30.69

28.00

iu/ml

0.13

(3008037) Lactate [Moles/volume] in Venous blood

442

1905

2.37

59.84

5.0

2.9

1.52

1.66

mmol/l

1.48

433

1853

(3019150) Specific gravity of Urine by Refractometry

2445

17760

1.51

59.16

6.9

4.6

1.01

1.19

kg/l

0.82

1736

11657

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

271

922

2.98

58.92

1.3

0.20

0.26

nmol/l

0.42

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

131

271

4.85

58.54

1.2

52.67

65.91

0.62

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

242

774

3.16

58.54

1.3

—

nmol/l

—

(3042631) Mycobacterium sp identified in Specimen

307

1125

2.77

58.21

2.6

2.9

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

137

296

4.65

58.10

1.2

1.1

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

1034

6129

1.76

57.45

4.1

2.6

56.52

63.79

ml/min/173m2

6.36

518

2532

(3010375) cycloSPORINE [Mass/volume] in Blood

117

225

5.21

56.88

35.6

26.8

106.95

109.58

ug/l

0.17

188

(3045424) Erythrocytes [Presence] in Urine

727

3874

1.94

56.80

2.9

2.1

0.00

0.24

estimate

0.50

204

1063

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

240

780

3.11

56.51

1.2

1.3

0.19

nmol/l

0.65

186

641

(3039000) Anion gap in Blood by calculation

365

1481

2.51

56.38

10.0

6.4

11.64

11.14

mmol/l

1.64

340

1303

(3018572) Chloride [Moles/volume] in Blood

365

1482

2.51

56.30

10.0

6.4

98.92

105.17

mmol/l

37.71

340

1304

(44790047) Parainfluenza type 1 nucleic acid detection

257

875

2.97

55.80

1.7

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

257

875

2.97

55.80

1.7

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

257

875

2.97

55.80

1.7

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

257

875

2.97

55.80

1.7

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

389

1637

2.42

55.52

1.5

1.6

—

(3036782) Glucose [Moles/volume] in Pleural fluid

240

798

3.04

54.33

1.4

1.3

6.55

6.20

mmol/l

1.01

224

736

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

485

2263

2.19

54.32

2.7

2.1

0.04

0.03

g/l

0.13

429

1995

(3011288) Drugs identified in Urine by Screen method Nominal

232

760

3.08

53.89

4.5

2.8

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

334

1330

2.55

53.66

1.3

56.67

198.06

titre

—

(3044007) Cell count panel - Peritoneal fluid

118

241

4.91

53.55

2.5

1.6

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

358

1476

2.47

53.42

1.6

1.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

303

1158

2.65

52.92

1.4

1.5

6.91

13.95

u/ml

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

179

505

3.57

52.88

1.3

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

230

758

3.06

52.88

1.5

1.8

—

(3019225) pH of Specimen

1293

8309

1.64

52.88

7.0

3.8

7.39

7.36

12.40

1068

5800

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

332

1334

2.53

52.34

1.3

187.63

350.69

titre

1.03

116

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

151

386

3.93

51.46

2.2

1.9

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

312

1228

2.58

51.34

2.5

1.7

393.52

285.97

mu/l

3.62

287

1136

(3035933) Granulocytes/Leukocytes in Blood

364

1542

2.40

51.17

4.3

3.3

59.96

58.05

1.65

364

1542

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

174

495

3.54

50.77

1.3

1.4

—

(3004451) EKG impression Narrative

152

395

3.87

50.63

1.4

1.2

—

(4198724) Urine methamphetamine measurement

139

6.19

50.25

3.1

3.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

170

480

3.56

50.17

1.7

1.4

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

465

2206

2.15

49.89

2.7

2.1

0.00

g/l

0.37

393

1892

(40757494) Bilirubin.total [Moles/volume] in Blood

151

396

3.83

49.66

3.5

2.1

23.88

37.17

umol/l

0.54

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

239

835

2.89

49.55

1.3

584.57

401.21

u/l

0.64

226

797

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

126

6.43

49.13

1.0

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

248

888

2.82

49.13

3.6

2.1

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

199

631

3.18

48.87

1.5

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

199

631

3.18

48.87

1.5

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

199

631

3.18

48.87

1.5

1.7

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

128

301

4.27

48.83

1.8

1.5

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

278

1061

2.65

48.69

2.1

1.8

29.14

25.04

ug/l

0.39

268

1035

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

267

1003

2.69

48.26

1.1

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

403

1830

2.24

48.19

2.4

2.2

89.05

91.16

0.87

389

1767

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

165

470

3.53

48.07

1.7

1.4

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

163

5.59

47.85

1.2

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

282

1096

2.60

47.62

1.6

1.5

5669.08

2422.95

e6/l

0.83

227

776

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

100

197

5.08

47.35

3.3

2.5

148.54

138.01

nmol/l

0.22

174

(3024932) HLA-DR beta [Type]

135

6.07

47.05

1.0

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

214

724

2.98

47.02

1.9

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

363

1595

2.31

46.93

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

363

1595

2.31

46.93

1.5

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

174

524

3.34

46.49

1.7

1.4

—

(3024471) HLA-A [Type]

140

5.93

46.47

1.0

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

175

5.32

46.36

1.0

1.1

—

(40768806) Pleura Pathology biopsy report

251

941

2.69

45.55

1.6

1.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

191

5.03

44.96

5.7

2.4

10.63

9.99

kpa

0.98

191

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

191

5.03

44.96

5.7

2.4

4.71

5.05

kpa

1.87

191

(4035726) Immunohistochemistry procedure

1082

6909

1.63

44.84

1.5

1.4

—

(3052851) Hemolysis interference index of Serum or Plasma

428

2049

2.13

44.81

4.4

3.2

1.90

1.74

index

0.21

239

1030

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

214

748

2.88

44.35

1.2

57.95

61.43

u/l

0.41

197

649

(3023419) Bacteria identified in Sputum by Culture

265

1042

2.57

43.70

2.3

2.5

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

212

5274

0.38

43.67

1.8

2.1

3.13

3.46

ratio

3.74

171

4208

(3017817) Protein [Mass] in Urine collected for unspecified duration

178

566

3.16

43.54

2.2

923.84

915.72

0.02

178

560

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

207

718

2.90

43.51

1.6

1.8

—

(3016879) Cocaine [Presence] in Urine

266

1052

2.56

43.35

3.5

2.1

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

183

5.03

43.10

1.5

1.3

219.32

27.80

g/l

0.47

142

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

418

2017

2.11

42.86

1.5

11.25

16.66

iu/ml

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

370

1704

2.20

42.72

2.6

2.5

218.31

199.53

2.59

352

1615

(3048689) Calprotectin [Mass/mass] in Stool

1217

8081

1.57

42.68

2.4

2.2

208.63

141.45

ug/g

4.64

950

6287

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

133

359

3.72

42.01

1.4

1.2

84.00

81.92

0.14

(3028308) Erythrocytes [#/volume] in Pleural fluid

252

987

2.58

41.90

1.6

1.5

60440.73

48533.61

e6/l

0.28

169

556

(3014051) Protein [Presence] in Urine by Test strip

2497

19238

1.40

41.05

4.9

3.1

0.06

0.07

0.02

675

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

417

2045

2.07

40.94

2.8

2.2

0.00

g/l

-0.00

391

1886

(3022493) Free Hemoglobin [Mass/volume] in Plasma

114

284

4.02

40.33

3.6

3.9

72.06

64.91

mg/l

0.42

186

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

243

953

2.57

40.31

1.5

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

248

983

2.55

40.24

1.5

1.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

262

1067

2.48

40.15

1.4

1.6

0.64

0.80

g/l

1.85

180

824

(3024522) Salmonella sp identified in Specimen by Organism specific culture

243

962

2.55

39.53

1.5

1.4

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

198

4.65

39.30

1.4

16.40

16.08

pmol/l

0.20

157

(3012565) Volume of 24 hour Urine

112

281

3.99

39.25

1.8

2.1

2150.83

1830.98

1.96

239

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

166

539

3.09

39.22

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

271

1135

2.41

39.07

3.6

2.0

—

(3003129) Base excess in Capillary blood by calculation

229

886

2.61

39.06

3.2

2.3

0.24

0.86

mmol/l

1.16

214

859

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

353

1656

2.16

38.91

1.7

3.34

3.59

iu/l

0.28

129

582

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

383

1873

2.08

37.88

2.8

3.4

774.29

813.37

u/ml

0.03

351

1696

(3027008) Opiates [Presence] in Urine

269

1141

2.38

37.71

3.6

1.8

—

(3028300) Cannabinoids [Presence] in Urine

269

1146

2.37

37.34

3.8

2.0

—

(3017354) Segmented neutrophils/Leukocytes in Blood

229

909

2.54

37.06

3.6

3.9

62.26

57.07

3.10

202

785

(21494755) Public health laboratory ask at order entry panel

140

3912

0.34

36.98

1.3

1.4

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

181

641

2.84

36.67

1.3

1.2

—

44.80

—

(3023420) DNA double strand Ab [Units/volume] in Serum

504

2743

1.87

36.57

2.1

1.7

10.47

7.38

iu/ml

0.78

142

626

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

216

839

2.59

36.56

1.1

1.66

1.54

g/l

2.81

194

751

(3044889) 12 lead EKG panel

5727

50712

1.35

36.42

5.9

4.2

0.33

3007.93

0.68

137

(3042111) Morphology [Interpretation] in Bone marrow Narrative

287

1272

2.28

36.37

1.6

1.5

—

(3045788) Cell count panel - Pleural fluid

222

877

2.55

36.30

1.6

1.5

—

(40761511) CBC panel - Blood by Automated count

7619

70848

1.52

36.20

35.4

14.9

—

6.35

—

(3035880) pH of Pleural fluid

138

421

3.29

36.19

1.3

1.2

7.41

0.01

110

279

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

182

652

2.81

36.09

1.2

10.74

14.83

u/l

0.95

166

596

(3020564) Creatinine [Moles/volume] in Serum or Plasma

7923

74333

1.61

36.07

51.9

21.8

81.59

78.53

umol/l

7.03

7839

73213

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

239

981

2.46

36.03

2.6

91.03

750.71

u/ml

1.37

231

974

(3027944) Amphetamines [Presence] in Urine

261

1123

2.35

35.44

3.5

2.0

—

(4024509) Urine culture

633

3733

1.74

35.11

2.6

1.9

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

107

285

3.76

34.52

1.5

1.3

59.47

65.42

0.93

233

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

174

624

2.80

34.46

1.6

1.5

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

7814

73221

1.55

34.05

21.2

12.1

25.02

25.09

u/l

0.09

7663

70434

(3038515) Glucose [Moles/volume] in Venous blood

335

1624

2.09

33.91

5.0

3.1

7.65

7.66

mmol/l

0.01

327

1581

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

143

3787

0.36

33.63

1.6

1.8

3.18

3.47

mmol/l

2.02

101

2716

(3009214) Lutropin [Units/volume] in Serum or Plasma

276

1248

2.23

33.35

1.6

1.4

13.13

10.84

u/l

1.36

219

993

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

230

4.04

33.29

3.1

2.6

0.59

0.62

mmol/l

3.65

230

(3014148) Varicella zoster virus Ab [Titer] in Serum

163

577

2.84

33.09

1.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

495

2766

1.82

32.97

1.6

1.9

40.08

39.92

u/l

0.05

417

2422

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

167

601

2.79

32.87

1.4

12.88

13.20

u/l

0.24

161

571

(40762365) Oxygen content in Arterial blood by calculation

104

5.76

32.73

3.1

2.6

14.42

14.98

ml/dl

0.74

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

7250

67044

1.43

32.68

38.9

16.2

75.69

75.60

ml/min/173m2

0.12

6963

62403

(3027456) Digoxin [Moles/volume] in Serum or Plasma

409

2159

1.92

32.56

3.9

3.4

0.83

0.81

nmol/l

0.41

325

1735

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

192

4.32

32.45

1.3

1.2

37.09

21.88

0.63

(3025468) Yersinia sp identified in Specimen by Organism specific culture

222

926

2.41

32.34

1.5

1.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

455

2493

1.85

32.29

1.3

1.2

1.47

1.11

u/ml

0.18

210

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

128

401

3.20

32.19

2.4

2.2

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

184

704

2.63

32.15

1.5

1.6

30.38

26.66

u/ml

0.33

139

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

326

1598

2.06

32.04

1.5

1.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

184

706

2.62

31.97

1.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

222

931

2.40

31.96

1.5

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

222

933

2.40

31.81

1.5

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

203

820

2.49

31.71

3.6

4.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

181

695

2.62

31.41

2.7

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

230

991

2.34

31.16

1.2

1.1

—

(3000919) Neutrophils/Leukocytes in Pleural fluid

208

4.08

30.89

1.4

1.3

21.96

20.47

0.17

186

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

163

4.53

30.79

1.1

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

6.35

30.75

3.4

3.5

38.86

40.45

umol/l

0.18

(3028192) IgG subclass 2 [Mass/volume] in Serum

178

686

2.61

30.67

1.4

2.77

2.92

g/l

0.50

111

493

(3024139) IgG subclass 3 [Mass/volume] in Serum

178

686

2.61

30.67

1.4

0.40

0.43

g/l

0.53

113

492

(3001893) Eosinophils/Leukocytes in Pleural fluid

240

3.83

30.62

1.4

4.19

2.97

0.59

197

(3027135) IgG subclass 1 [Mass/volume] in Serum

178

687

2.60

30.58

1.4

6.90

6.87

g/l

0.03

113

494

(4062490) Immunoglobulin typing, IgG

175

670

2.62

30.56

1.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

256

1166

2.21

30.41

3.6

1.6

0.96

0.84

nmol/l

0.95

217

979

(3044927) Protein electrophoresis panel - Urine

194

788

2.47

29.97

1.2

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

159

4.52

29.87

1.5

1.2

134.81

152.08

nmol/24h

0.11

159

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

146

520

2.82

29.34

1.2

100.47

111.52

pmol/l

1.22

146

520

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

317

1589

2.02

29.31

2.4

2.2

190.46

78.93

ug/min

2.16

179

870

(42529406) Shigella sp [Presence] in Stool by Culture

355

1854

1.94

29.18

1.3

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

354

1849

1.94

29.08

1.3

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

135

464

2.92

28.97

1.1

—

(3003694) ABO and Rh group [Type] in Blood

2362

18848

1.33

28.95

1.5

1.3

—

(3005322) IgE [Units/volume] in Serum or Plasma

637

3960

1.64

28.86

1.4

1.3

429.62

250.28

u/ml

1.44

585

3634

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

251

3.66

28.73

1.9

1.6

8.42

4.88

nmol/l

0.55

208

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

351

1837

1.93

28.67

1.3

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

112

348

3.22

28.59

1.4

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

112

348

3.22

28.59

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

112

348

3.22

28.59

1.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

146

528

2.77

28.52

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

256

1200

2.15

28.32

1.4

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

154

4.47

28.27

1.6

1.2

1.15

1.18

mmol/l

2.97

154

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

6114

55446

1.31

28.20

45.7

20.2

14.23

13.79

90.89

6069

54564

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

171

4.26

28.13

1.1

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

250

3.60

27.39

2.9

1.5

2.01

1.93

umol/l

0.28

230

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

179

4.13

27.35

1.0

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

6.45

26.92

2.3

17.72

17.85

umol/l

0.02

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

127

442

2.88

26.68

1.1

299.33

292.00

mg/l

0.28

114

395

(3029634) Reagin Ab [Titer] in Serum by VDRL

173

704

2.47

26.66

1.9

—

3.42

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

121

416

2.91

26.00

3.8

4.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

144

543

2.66

25.98

1.2

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

370

2039

1.84

25.77

1.8

1.5

0.20

2.99

iu/ml

0.90

426

(3023410) Appearance of Cerebral spinal fluid

145

554

2.62

25.50

1.7

—

(3007461) Platelets [#/volume] in Blood

7927

75169

1.50

25.48

57.4

25.1

262.69

246.43

e9/l

65.34

7805

73316

(3035941) MCH [Entitic mass]

7927

75175

1.49

25.40

57.1

25.0

30.55

30.38

12.46

7843

74061

(3024731) MCV [Entitic mean volume] in Red Blood Cells

7927

75177

1.49

25.38

57.2

25.0

91.43

91.54

1.14

7847

74062

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

7927

75180

1.49

25.34

58.9

25.5

36.74

40.22

118.96

7842

74033

(3026361) Erythrocytes [#/volume] in Blood

7927

75182

1.49

25.31

57.4

25.1

4.08

4.43

e12/l

307.65

7789

73012

(3010813) Leukocytes [#/volume] in Blood

7927

75188

1.49

25.24

57.5

25.1

7.40

6.77

e9/l

51.28

7785

73002

(3000963) Hemoglobin [Mass/volume] in Blood

7927

75190

1.49

25.21

58.1

25.3

123.27

133.67

g/l

307.65

7846

74107

(3017315) Amylase [Enzymatic activity/volume] in Urine

113

381

2.97

25.15

1.4

1.2

197.38

311.67

u/l

1.44

101

355

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

157

628

2.51

25.12

1.4

1.3

1.23

1.49

nmol/l

1.98

147

560

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

117

405

2.89

24.85

1.2

1.1

31.63

24.11

u/l

0.57

104

356

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

110

369

2.98

24.71

1.5

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

110

369

2.98

24.71

1.5

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

110

369

2.98

24.71

1.5

1.9

—

(3020961) Endomysium IgA Ab [Titer] in Serum

482

2905

1.68

24.57

1.1

286.36

137.78

titre

0.27

(3014271) Vancomycin [Susceptibility]

124

447

2.78

24.44

3.7

3.0

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

7125

66438

1.35

24.38

8.5

6.4

41.17

39.44

mmol/mol

36.19

6602

60727

(3051611) Lipemic interference index of Serum or Plasma

172

729

2.37

24.27

4.0

2.9

12.93

13.06

index

0.05

106

356

(3011412) CD3 cells [#/volume] in Blood

152

609

2.50

24.26

2.4

1789.65

1118.33

e6/l

0.53

135

546

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

117

412

2.84

24.09

1.2

1.1

93.34

83.29

u/l

0.40

104

362

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

109

370

2.95

23.99

1.5

1.9

—

(37021550) Renin [Units/volume] in Plasma --upright

126

4.51

23.68

1.5

1.2

228.94

54.98

mu/l

0.64

(3016750) Collection duration of Urine

104

347

3.00

23.61

2.0

2.2

506.61

494.03

min

0.43

253

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

5.89

23.55

1.1

—

(3045142) Bone marrow Pathology biopsy report

183

809

2.27

23.44

1.4

1.3

—

(3049717) Cytology report of Urine Cyto stain

489

2996

1.66

23.40

2.4

2.8

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

108

370

2.92

23.39

1.3

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

108

370

2.92

23.39

1.3

1.5

—

(3051651) Icteric interference index of Serum or Plasma

106

364

2.91

22.87

4.2

2.9

0.89

0.97

index

0.20

106

356

(3022145) Colonoscopy Study observation

1137

8368

1.40

22.69

1.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

166

717

2.32

22.47

1.3

1.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

7237

67829

1.34

22.44

6.4

5.3

6.23

5.97

mmol/l

31.82

6530

60817

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

270

3.22

22.34

1.1

1444.62

1551.64

miu/ml

0.38

270

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

261

3.25

22.21

2.2

1.9

7120.38

39274.31

u/ml

0.59

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

121

453

2.67

22.21

2.6

1.7

414.38

344.90

mu/l

0.94

100

360

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

138

4.19

21.97

1.2

14.85

18.70

pmol/l

0.25

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

256

1320

1.95

21.91

1.2

1.3

32.38

36.95

u/l

0.34

219

1128

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

116

430

2.70

21.72

1.5

9.19

5.87

u/l

0.95

339

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

5.43

21.66

1.6

—

(3026389) Candida sp identified in Specimen by Organism specific culture

216

1054

2.06

21.59

1.3

1.4

—

(1175426) CD3 cells/Lymphocytes in Blood

124

479

2.59

21.40

2.3

2.2

74.75

71.12

1.50

118

459

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

5.61

21.35

7.6

10.7

5.65

5.33

mmol/l

0.18

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

477

2974

1.63

21.29

3.0

3.5

905.52

1574.01

u/ml

0.54

415

2557

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

109

398

2.74

21.02

1.1

—

0.62

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

308

2.98

20.81

1.1

4.29

3.50

iu/ml

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

5.23

20.78

2.4

3.2

82.93

26.02

mg/l

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

167

3.76

20.61

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

118

454

2.60

20.54

2.4

2.2

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

160

708

2.26

20.51

1.5

22.24

30.71

2.68

421

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

110

410

2.68

20.40

1.2

41.95

26.57

u/l

0.88

328

(3004775) Volume in Urine collected for unspecified duration

125

497

2.52

20.34

2.2

784.55

632.20

2.60

319

(3042517) Benzodiazepines panel - Urine

16.76

20.32

2.7

2.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

121

4.28

20.29

1.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

200

971

2.07

20.29

1.9

1.5

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

113

429

2.63

20.22

2.4

1.5

83.42

84.23

umol/l

0.05

113

429

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

180

841

2.15

20.19

1.1

71.84

786.90

iu/ml

0.51

177

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

176

3.63

19.87

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

111

422

2.63

19.81

1.2

120.36

90.14

u/l

1.20

103

348

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

309

1749

1.78

19.75

1.6

1.9

11.27

11.81

mg/l

0.52

275

1617

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

126

512

2.46

19.60

1.1

1.2

114.00

170.00

titre

0.79

(3012898) Urea [Moles/volume] in Urine

6.37

19.40

1.4

1.2

92.96

173.16

mmol/l

4.75

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

119

4.19

18.97

1.7

1.6

1628.57

8440.00

u/ml

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

141

614

2.30

18.80

1.3

499.52

745.80

titre

0.35

(3001186) Copper [Moles/volume] in Serum or Plasma

130

3.99

18.49

1.7

1.1

16.62

16.71

umol/l

0.04

115

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

110

4.26

18.24

1.4

1.3

12.36

10.68

0.16

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

137

599

2.29

18.11

1.3

30.00

73.26

titre

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

19.19

18.06

3.7

4.3

—

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

5.55

17.96

2.5

2.0

56.35

59.50

0.16

(3024666) Lithium [Moles/volume] in Serum or Plasma

249

3.05

17.91

16.2

13.6

0.69

0.64

mmol/l

0.93

232

(3024891) Influenza virus A+B Ag [Presence] in Specimen

281

1593

1.77

17.89

1.3

1.2

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

15.19

17.83

2.8

2.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

332

2.74

17.65

3.8

2.8

1.52

1.32

0.45

332

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

482

3152

1.55

17.55

1.1

0.85

1.66

u/ml

—

(3010503) CD19 cells [#/volume] in Blood

104

409

2.54

17.38

2.5

2.4

955.64

144.44

e6/l

0.63

392

(3020717) Zinc [Moles/volume] in Serum or Plasma

346

2.68

17.38

2.3

1.3

16.43

23.92

umol/l

2.05

314

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

164

3.52

17.32

1.1

—

(40768804) Tissue Pathology biopsy report

3363

29359

1.22

17.29

2.4

2.2

—

(3018133) Calcium [Moles/volume] in Urine

4.63

17.26

1.8

1.4

2.41

2.77

mmol/l

0.47

(3008116) Ketones [Moles/volume] in Urine by Test strip

134

3.79

16.96

2.0

1.3

0.45

0.42

mmol/l

0.05

(40761539) Cells [Type] in Urine sediment by Light microscopy

176

3.40

16.95

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

169

3.42

16.57

1.7

1.9

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

142

3.65

16.37

2.0

1.9

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

133

3.74

16.35

1.2

291.11

281.78

pmol/l

0.08

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

12.02

16.20

5.4

6.5

202.60

155.24

e6/l

0.18

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

207

3.13

16.11

2.0

1.4

3.11

3.40

umol/l

0.24

177

(3017704) Immunofixation for Urine

378

2.54

16.04

1.6

—

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

5.77

15.98

2.3

2.0

12.10

18.04

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

385

2.52

15.94

1.1

371.38

284.60

mg/l

0.92

337

(36660697) Celiac disease serology panel - Serum

712

5126

1.41

15.92

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

408

2632

1.56

15.80

1.4

1.3

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

252

2.89

15.74

1.2

1.3

171.80

388.65

ug/l

0.52

139

(3036603) Volume of Urine

101

412

2.45

15.67

1.5

1.7

2054.15

1806.35

1.57

399

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

104

430

2.42

15.67

2.0

2.7

202.83

239.36

e6/l

0.99

374

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

347

2160

1.62

15.63

1.5

1.4

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

348

2.58

15.62

1.6

4.86

5.89

u/l

1.87

289

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

4.24

15.48

1.1

1.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

331

2044

1.63

15.41

1.3

63.74

40.86

u/ml

0.56

118

(4027681) Cerebrospinal fluid IgG ratio and IgG index

284

2.74

15.25

1.4

1.2

0.58

0.55

ratio

0.17

165

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

406

2.44

15.20

2.0

2.6

912.91

530.06

e6/l

0.45

332

(3028679) Herpes simplex virus Ab [Presence] in Serum

263

2.81

15.14

1.1

—

(3047189) Immunofixation for 24 hour Urine

319

2.63

15.13

1.6

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1441

0.32

15.05

1.1

1.2

0.55

0.62

ratio

0.85

235

(3024869) Neuronal Ab [Presence] in Serum

141

3.53

15.04

1.1

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

23.20

15.01

3.8

3.4

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

282

2.72

14.90

1.5

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

282

2.72

14.90

1.5

2.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

278

1656

1.69

14.89

1.3

1.2

3.18

5.16

u/ml

0.46

116

(3034274) Bile acid [Moles/volume] in Serum --fasting

410

2.41

14.89

1.8

1.9

17.97

10.98

umol/l

0.91

299

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

142

3.51

14.88

2.0

1.9

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

357

2.52

14.84

1.3

1.26

1.25

nmol/l

0.03

261

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

405

2.42

14.81

1.2

48.95

40.50

mg/l

0.97

336

(21494434) Karyotype in Bone marrow

139

665

2.09

14.78

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

270

2.73

14.43

1.4

1.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

287

2.68

14.41

1.6

2.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

121

555

2.18

14.35

1.6

1.4

40.41

32.92

u/l

1.23

462

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

151

3.36

14.26

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

202

1113

1.82

14.23

2.8

2.1

33.25

26.00

mg/l

0.99

396

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

4.26

14.08

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

158

809

1.95

13.95

1.2

24.89

44.61

u/ml

0.97

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

1547

0.37

13.94

1.2

1.56

1.53

g/l

0.34

1547

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

309

1925

1.61

13.91

1.3

3.47

4.01

u/ml

0.11

207

(40768441) Liver Pathology biopsy report

108

481

2.24

13.78

1.7

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

433

2923

1.49

13.61

1.8

1.6

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

127

3.53

13.55

1.4

1.2

1.97

1.79

mmol/l

0.05

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

551

3902

1.43

13.51

1.2

118.16

128.57

u/ml

0.29

196

1397

(3023383) Lactate [Moles/volume] in Pleural fluid

246

2.76

13.50

1.4

1.3

4.08

3.21

mmol/l

0.80

224

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

308

1933

1.60

13.46

1.4

1.3

4.08

5.03

u/ml

0.44

328

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

198

2.97

13.43

1.2

—

(3034891) Synovial lining cells/cells in Synovial fluid

369

2.41

13.40

1.4

1.5

1.25

3.94

2.67

(21494814) CD8 cells/Lymphocytes in Specimen

270

2.66

13.35

2.5

2.0

31.81

30.39

0.28

270

(3000330) Specific gravity of Urine by Test strip

558

3970

1.42

13.33

5.7

3.6

1.01

1.02

ratio

18.62

507

3573

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

288

2.60

13.27

1.1

538.17

349.71

ng/l

0.33

(40768443) Skin Pathology biopsy report

513

3608

1.44

13.06

1.3

1.2

—

(3010838) Calcium [Moles/time] in 24 hour Urine

195

1094

1.79

12.98

1.7

1.8

3.68

4.91

mmol/24h

7.12

162

941

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

109

500

2.18

12.97

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

139

699

1.99

12.96

1.2

1.3

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

117

553

2.11

12.90

1.7

1.5

0.22

0.28

nmol/l

0.71

387

(3026726) Creatinine [Moles/volume] in Specimen

5.17

12.79

2.2

2.1

270.58

619.58

umol/l

0.45

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

365

2.38

12.78

1.1

—

(3021788) Differential panel - Synovial fluid

249

1507

1.66

12.61

1.6

1.5

—

1.00

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

144

3.25

12.49

1.9

3.2

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

4.24

12.47

1.3

0.59

0.25

u/ml

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

4.34

12.44

1.0

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

4.97

12.25

1.1

—

(3041354) Potassium [Moles/volume] in Venous blood

170

934

1.82

12.15

3.4

2.3

4.15

4.07

mmol/l

1.41

170

926

(3035285) Chloride [Moles/volume] in Venous blood

170

934

1.82

12.15

3.4

2.3

99.86

105.57

mmol/l

17.62

170

926

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

4.22

12.01

1.1

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

172

956

1.80

11.85

1.5

1.6

65.25

58.86

1.29

105

593

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1481

12270

1.24

11.81

1.3

45.41

36.48

iu/ml

1.08

491

3752

(3020393) Adenovirus Ag [Presence] in Stool

4.26

11.77

1.8

1.3

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

14.52

11.70

1.2

1.1

—

mmol/l

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

405

2.24

11.70

2.3

2.6

1.20

0.64

e9/l

0.47

380

(3004616) Nuclear Ab [Presence] in Serum

172

963

1.79

11.57

1.4

1.3

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

4.20

11.56

1.3

1.5

—

(3022621) pH of Urine by Test strip

777

5960

1.32

11.56

4.2

3.0

6.27

6.07

7.36

552

4132

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

274

2.51

11.45

1.1

1.25

1.14

u/l

0.32

123

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

148

794

1.86

11.44

3.6

3.7

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

3.76

11.28

1.1

17.13

19.40

u/l

0.33

(3013727) Leukocytes other/Leukocytes in Blood

202

2.76

11.25

3.6

3.2

57.78

54.50

0.49

194

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

280

2.46

10.96

1.3

1.2

—

(3000034) Microalbumin [Mass/volume] in Urine

116

583

1.99

10.91

2.5

2.7

91.45

23.98

mg/l

1.78

411

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

154

850

1.81

10.89

3.4

3.5

7.03

19.66

nmol/l

0.77

146

832

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

283

1833

1.55

10.87

1.3

1.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.06

10.71

1.1

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

113

3.35

10.63

1.4

1.2

176.76

60.94

u/l

0.47

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

3.74

10.58

1.5

1.3

77.22

69.98

0.64

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

354

2423

1.47

10.45

1.7

1.6

32.15

20.58

u/ml

0.92

462

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

239

2.54

10.45

1.1

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

561

4163

1.36

10.43

1.3

54.97

60.31

au/ml

0.15

299

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

605

4542

1.35

10.43

2.4

2.5

19.28

22.61

au/ml

0.41

424

(3033705) Calcium.ionized [Moles/volume] in Venous blood

162

922

1.76

10.36

3.5

2.3

1.18

1.20

mmol/l

1.85

162

914

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1240

10212

1.24

10.35

15.2

7.3

—

(3028433) Virus identified in Specimen by Culture

235

2.54

10.29

1.2

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

179

2.78

10.22

1.1

1.2

—

(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid

18.63

10.20

5.6

5.0

15.90

17.50

mmol/l

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

10.49

10.19

5.7

2.0

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

745

5781

1.30

10.18

1.6

1.5

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

6749

64178

1.19

10.10

4.9

4.2

1.24

1.26

mmol/l

0.70

6011

57355

(3032057) Clostridioides difficile [Presence] in Stool

164

2.85

10.08

1.8

1.7

—

(1761482) Bacteria [#/volume] in Urine by Culture

297

1978

1.51

10.05

6.8

4.5

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

168

2.78

9.66

2.4

2.3

2444.81

219.27

ug/l

0.49

168

(40757373) Influenza virus identified in Isolate

143

2.92

9.43

1.8

1.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

463

2.02

9.42

2.2

1.8

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

171

2.74

9.35

1.3

1.2

1.45

1.67

mmol/l

0.66

102

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

194

2.62

9.31

1.7

1.5

0.35

0.40

ug/l

0.48

127

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

234

1507

1.56

9.28

1.2

1.1

3.58

3.82

—

146

(3023323) Follitropin [Units/volume] in Serum or Plasma

251

1645

1.53

9.20

1.7

1.4

29.05

32.39

iu/l

0.79

210

1400

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

427

2.05

9.19

1.2

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

4.85

9.19

1.1

2507.33

4223.37

ng/l

0.46

(4281824) Cell count and differential, peritoneal fluid

149

859

1.73

9.16

1.3

1.1

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

111

585

1.89

9.16

1.9

1.8

4.60

3.96

mg/l

0.77

102

556

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

238

2.43

9.07

1.2

1.1

26.18

17.42

u/ml

0.17

(3026051) Granulocytes/Leukocytes in Pleural fluid

197

2.58

9.04

1.5

1.3

27.48

26.79

0.05

165

(3028717) Thiamine [Mass/volume] in Blood

3.66

9.01

1.1

1.2

70.25

63.75

ug/l

0.58

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

8.21

8.99

3.6

2.0

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

492

1.97

8.97

1.2

1.4

0.27

1.40

u/ml

3.48

302

(3001019) Free T4 and TSH panel - Serum or Plasma

126

2152

0.57

8.81

1.7

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

128

716

1.78

8.75

1.3

1.2

73.00

70.63

u/ml

0.04

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

351

2.13

8.64

3.3

2.9

36.69

37.15

0.07

208

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

7.55

8.57

1.1

1.4

1.36

1.18

iu/ml

0.15

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

233

1528

1.53

8.54

1.2

1.1

9.61

10.92

eliau/ml

—

141

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

420

2.02

8.48

1.2

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

167

1017

1.64

8.41

1.2

1.77

4.80

u/ml

1.52

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

115

3.03

8.39

2.3

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

4.26

8.28

1.6

1.4

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.42

8.25

1.2

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

213

1386

1.54

8.12

1.3

1.2

56.14

46.50

u/ml

0.31

146

(44786800) Granulocytes/Leukocytes in Body fluid

107

3.07

8.10

1.3

1.4

24.77

21.32

0.23

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.31

8.07

1.2

1.1

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

437

1.96

7.96

1.4

1.5

15.02

13.46

umol/l

0.92

407

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

143

850

1.68

7.93

1.3

1.2

3.43

3.91

u/ml

0.27

385

(3038026) Centromere Ab [Units/volume] in Serum

112

624

1.79

7.81

1.3

1.2

10.71

58.81

u/ml

—

(3003327) Ova and parasites identified in Stool by Light microscopy

301

2121

1.42

7.71

1.6

1.7

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

104

569

1.82

7.71

1.2

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

190

2.46

7.65

1.2

1.3

92.99

134.29

nmol/l

1.66

129

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

161

2.60

7.62

2.1

2.4

6.68

7.24

mmol/l

0.63

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

252

2.25

7.60

1.0

1.1

—

(3007463) Buprenorphine [Presence] in Urine

18.21

7.56

4.7

4.2

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1342

11478

1.19

7.45

1.3

12.38

12.95

u/ml

0.10

497

4260

(3000475) Leukocytes [#/volume] in Synovial fluid

290

2044

1.42

7.43

1.9

1.6

15134.85

14569.15

e6/l

0.09

209

1455

(3014891) Appearance of Pleural fluid

113

2.90

7.40

1.8

1.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

176

2.49

7.33

1.1

82.90

85.15

0.14

(3017509) Phencyclidine [Presence] in Urine

5.90

7.31

1.3

—

(4034850) Laboratory test

328

2369

1.39

7.30

14.7

11.2

—

(3016244) Insulin [Units/volume] in Serum or Plasma

244

2.24

7.29

2.5

3.1

13.74

20.98

mu/l

1.21

230

(4268621) Lupus anticoagulant assay

107

605

1.76

7.14

2.3

2.2

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

19.86

7.09

8.2

5.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

173

2.47

7.09

1.1

1.2

84.96

86.85

0.09

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

4.44

7.08

1.2

1.1

1.48

4.52

u/l

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

139

2.65

7.01

1.1

0.79

0.64

umol/24h

0.61

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

388

1.95

7.00

1.2

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

118

695

1.69

6.83

2.1

2.3

2.09

1.84

u/field

0.27

356

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1213

13904

0.84

6.83

3.1

3.4

0.79

ug/l

0.01

867

9432

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

3.53

6.76

1.0

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

3.15

6.73

2.9

2.5

0.62

0.56

u/field

0.09

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

133

812

1.63

6.72

2.6

2.0

3205.13

4506.08

u/l

0.23

318

(40759836) Histone Ab [Presence] in Serum by Immunoblot

480

1.83

6.65

1.2

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

2.91

6.57

1.3

1.2

52.73

51.96

0.02

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

390

1.92

6.57

1.9

1.41

2.70

u/field

1.26

254

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

186

2.35

6.55

1.2

1.4

118.74

111.88

0.76

169

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.68

6.54

1.4

1.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

405

1.89

6.52

1.1

3.18

11.22

nmol/l

1.09

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

323

4273

0.74

6.48

1.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

558

1.75

6.43

1.6

1.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.98

6.38

1.1

1.0

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

195

2.30

6.35

1.2

1.3

0.31

g/l

0.27

155

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

107

2.79

6.30

1.2

1.3

56.19

974.83

ng/l

0.58

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

490

1.79

6.24

1.2

1.1

—

(3033086) Enterovirus Ab [Titer] in Serum

9.17

6.24

1.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

179

1192

1.50

6.23

1.3

190.93

214.68

miu/ml

0.22

466

(3019420) Tryptase [Mass/volume] in Serum or Plasma

350

1.93

6.17

1.1

1.6

8.43

9.33

ug/l

0.19

319

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

7174

69228

1.16

6.15

6.4

5.8

2.35

2.69

mmol/l

189.22

6497

62818

(3052592) Norovirus Ag [Presence] in Stool

155

2.44

6.14

1.2

—

(1761868) Lipid panel - Serum or Plasma

2125

23205

0.88

6.10

4.0

3.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

380

1.89

6.07

1.6

1.3

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

116

2.66

5.97

1.1

—

28.33

u/ml

—

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

3.43

5.91

1.5

1.1

22.80

19.16

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

4.97

5.81

1.1

1.4

67.94

40.65

mg/l

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

135

859

1.57

5.81

1.3

1.2

3.97

3.85

u/ml

0.03

318

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

124

775

1.60

5.76

1.1

117.24

115.40

0.25

116

697

(3000060) B lymphocytes [#/volume] in Blood

148

2.42

5.74

2.3

2.5

0.14

1.44

e9/l

1.30

(3039162) Centromere protein B Ab [Units/volume] in Serum

128

807

1.58

5.74

1.3

38.10

64.99

u/ml

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

7025

67805

1.14

5.54

5.7

5.1

4.30

4.63

mmol/l

118.20

6358

61865

(37019676) Renin [Units/volume] in Plasma --supine

8.40

5.52

1.1

22.10

23.98

mu/l

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.91

5.47

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

129

825

1.56

5.46

1.1

—

(4015189) Microbial culture of sputum

229

2.09

5.41

2.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

398

3099

1.29

5.40

1.1

—

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

3.59

5.40

1.1

1.3

42.33

43.42

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

476

1.74

5.38

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

476

1.74

5.38

1.2

—

(3020491) Glucose [Moles/volume] in Blood

492

1.72

5.34

1.8

2.0

8.11

6.90

mmol/l

1.54

326

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

456

1.75

5.31

1.2

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

2.99

5.28

2.7

3.7

1.45

1.24

mg/l

0.16

(3018333) Ribosomal P Ab [Presence] in Serum

444

1.75

5.21

1.2

1.1

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

5.35

5.17

1.3

1.8

0.33

2.56

mg/l

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

5.35

5.17

1.3

1.8

4.29

1.44

mg/l

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

5.35

5.17

1.3

1.8

1.15

2.46

mg/l

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

5.35

5.17

1.3

1.8

0.54

1.28

mg/l

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

5.35

5.17

1.3

1.8

0.49

2.79

mg/l

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

5.35

5.17

1.3

1.8

0.64

2.37

mg/l

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

5.35

5.17

1.3

1.8

1.20

1.33

mg/l

—

(3023511) Choriogonadotropin [Units/volume] in Urine

359

1.83

5.13

1.7

1.2

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

114

2.53

5.11

2.0

3.4

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

463

1.72

5.05

1.2

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

305

1.89

5.01

1.2

1.1

—

(4195642) Thrombophilia screening test

121

779

1.55

5.01

1.2

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

3.53

4.97

1.0

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

6.83

4.91

1.2

1.6

0.30

0.36

iu/ml

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.67

4.91

1.1

1.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.94

4.90

2.0

2.7

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

4.97

4.89

1.3

1.8

0.32

1.87

mg/l

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

374

2929

1.28

4.89

1.8

1.9

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

136

2.34

4.80

2.2

1.5

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

181

2.14

4.76

1.1

1.0

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

11.35

4.76

1.8

1.9

1.36

2.12

g/l

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

6.42

4.73

1.2

1.1

—

(1002224) Polysomnography panel

165

2303

0.71

4.73

1.0

1.1

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

537

1.63

4.59

2.0

1.7

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

108

693

1.55

4.57

1.1

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

2.53

4.46

1.7

1.6

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

2.84

4.41

1.8

2.1

0.97

0.99

mmol/l

—

(3013637) Mi-2 Ab [Presence] in Serum

222

1.97

4.34

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

222

1.97

4.34

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

222

1.97

4.34

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

222

1.97

4.34

1.2

1.1

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

2.80

4.31

1.1

1.0

23.44

25.33

iu/ml

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.86

4.26

1.0

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

158

2.14

4.17

1.1

—

1.40

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.60

4.15

1.1

1.2

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

2.60

4.15

1.0

1.1

12.15

9.13

mg/l

0.55

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

6942

67253

1.12

4.12

5.6

5.0

1.51

1.50

mmol/l

2.09

6249

60904

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

4.30

4.08

1.7

1.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.78

4.05

1.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

161

2.10

3.99

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

337

1.74

3.98

1.9

1.7

36.98

40.10

g/l

2.25

337

(3010144) Erythrocytes [#/volume] in Synovial fluid

116

781

1.48

3.98

1.5

1.4

97975.35

165285.13

e6/l

0.45

513

(3045683) HLA typing for celiac disease panel - Blood or Tissue

272

1.83

3.97

1.0

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.74

3.95

1.4

1.7

49.95

48.65

umol/l

0.07

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

464

3826

1.21

3.88

4.7

4.0

103.78

92.71

u/ml

0.21

445

3676

(3001964) Herpes simplex virus Ag [Presence] in Specimen

184

2.00

3.83

1.8

1.3

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

5.96

3.78

1.6

1.3

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

4.26

3.78

1.5

1.4

—

(3044009) aPTT.lupus sensitive (LA screen)

2.98

3.63

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

106

716

1.47

3.62

1.2

1.1

3.33

4.01

eliau/ml

0.24

268

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

3.09

3.59

1.8

3.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.84

3.57

1.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

106

2.25

3.38

1.1

1.2

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

4.05

3.36

1.0

1.1

220.55

279.00

nmol/l

1.01

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

202

1.87

3.30

1.3

1.8

179.63

183.69

0.10

189

(3013166) Neutrophils/Leukocytes in Synovial fluid

231

1.81

3.28

1.5

1.4

63.40

55.89

0.64

197

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

8.51

3.24

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

169

1.94

3.20

1.2

—

(3024263) Appearance of Synovial fluid

376

1.61

3.18

1.9

1.6

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

117

828

1.41

3.16

1.1

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

6.32

3.16

1.3

1.1

195.16

257.90

u/ml

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

389

3228

1.20

3.12

1.8

1.9

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

3.23

3.10

1.0

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.71

3.10

1.0

1.2

2.15

1.72

umol/24h

0.46

(3008536) Aspergillus sp Ab [Presence] in Serum

158

1.95

3.06

1.8

1.9

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

3.64

3.05

1.5

1.4

—

(4146454) Self-monitoring of blood glucose

114

810

1.40

3.03

3.3

2.5

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

126

911

1.38

3.02

1.1

17.99

15.95

au/ml

—

170

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

3.15

3.02

1.0

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

549

1.49

2.99

1.0

216.97

354.01

ng/l

13.54

374

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

3.31

2.98

2.2

1.5

6.10

3.96

nmol/l

0.32

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

550

1.48

2.97

1.0

761.79

712.02

ng/l

0.41

361

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2765

28930

0.92

2.96

2.1

1.9

1.33

1.30

mmol/l

0.61

2221

23356

(3036180) Methadone [Presence] in Urine

9.92

2.96

2.6

3.6

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.73

2.93

1.0

1.1

6.00

15.14

u/l

1.00

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

189

1.84

2.93

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

448

1.53

2.91

4.1

5.1

251.98

113.57

u/ml

0.41

140

(3013139) Helicobacter pylori Ag [Presence] in Stool

559

4816

1.16

2.90

1.2

1.3

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

3.22

2.90

1.0

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

3.22

2.90

1.0

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

494

0.52

2.89

1.3

1.4

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

554

1.47

2.87

1.0

29.96

46.76

ng/l

8.51

372

(3050794) Legionella sp Ab [Presence] in Serum

2.67

2.84

1.0

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

355

0.45

2.79

1.3

1.5

—

(4094501) Cardiovascular stress test using bicycle ergometer

141

1840

0.76

2.78

1.1

—

(3002256) Pathology report gross observation

1109

10016

1.11

2.77

1.4

1.3

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

3.55

2.75

1.1

1.6

322.99

487.51

nmol/l

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.52

2.73

1.1

1.3

—

(3013336) Amino acids [Identifier] in Serum or Plasma

8.27

2.73

6.2

3.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

152

1.90

2.68

1.1

740.00

734.37

titre

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2478

23255

1.08

2.65

5.3

5.8

3.75

3.55

ug/l

0.13

2181

20953

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

174

1.83

2.65

1.0

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

125

1.99

2.64

1.2

81.82

77.81

0.12

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

182

1.80

2.62

1.5

1.7

10.64

9.37

ug/l

0.63

182

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.16

2.61

1.3

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.16

2.61

1.3

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.16

2.61

1.3

1.2

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.44

2.57

2.7

2.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

3.97

2.54

1.0

—

(3001488) Cow milk IgE Ab [Units/volume] in Serum

7.09

2.53

1.0

—

(36303858) Crystals [Presence] in Urine

7.09

2.53

1.0

1.3

—

(3006270) Folate [Moles/volume] in Blood

638

1.40

2.49

1.4

1.2

312.51

329.33

nmol/l

0.30

515

(3002619) Bacteria identified in Specimen by Culture

200

1.74

2.48

1.4

1.3

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

315

1.58

2.46

1.2

1.1

1.08

1.07

ratio

0.21

255

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

2.14

2.45

1.1

1.3

97.30

99.11

ug/l

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

115

1.99

2.45

1.1

1.3

25.22

41.75

mg/l

1.59

104

(3016273) Islet cell 512 Ab [Units/volume] in Serum

3.78

2.44

1.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.53

2.40

1.0

2.0

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

123

1.94

2.39

1.2

78.60

73.33

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.87

2.38

1.1

1.2

—

(3018291) Platelet Ab [Presence] in Serum

4.96

2.38

1.5

1.0

—

(3034614) HLA Ag [Interpretation]

6.20

2.36

1.4

1.8

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.19

2.32

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

971

8796

1.11

2.31

1.5

1.4

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.80

2.31

1.7

1.1

—

(4212803) Bone marrow aspirate examination

2.29

2.27

1.1

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

191

1.72

2.26

1.2

1.1

—

(3019174) dRVVT (LA screen)

2.44

2.23

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

731

0.66

2.20

1.4

1.6

998.65

984.86

mu/l

0.04

599

(3038177) Helicobacter pylori Ab [Presence] in Serum

121

921

1.31

2.17

1.3

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

149

1860

0.79

2.15

2.2

1.7

5.60

4.59

mg/l

0.48

128

1366

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.22

2.13

8.2

5.0

—

(40768795) Lymph node Pathology biopsy report

108

812

1.32

2.12

1.3

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

376

1.48

2.11

1.3

1.4

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.76

2.11

1.1

1.0

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

129

1.85

2.11

2.3

2.8

95.73

135.60

au/ml

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

187

1509

1.23

2.09

1.6

1.4

350.17

208.82

pmol/l

0.79

178

1473

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

2.43

2.06

1.0

—

(37208534) Antinuclear antibody arbitrary concentration in serum

182

1.69

2.05

1.0

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.88

2.05

1.4

1.1

—

(44813793) Dust mix specific IgE antibody measurement

446

1.43

2.01

1.0

1.1

—

(3025549) Creatine [Moles/time] in 24 hour Urine

2.30

2.01

1.5

1.3

—

(40762887) Creatinine [Moles/volume] in Blood

2.21

1.97

1.3

1.5

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.03

1.96

1.9

1.6

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

4.51

1.93

1.8

1.3

30.43

41.02

umol/24h

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.93

1.90

1.2

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.29

1.84

1.1

1.0

0.04

0.03

u/ml

0.21

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

173

1.67

1.84

1.9

1.7

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

4.14

1.81

1.2

1.1

—

(3001556) Androgen free Index in Serum or Plasma

3.02

1.78

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

280

1.49

1.70

1.2

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

132

1.73

1.69

1.2

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

160

1306

1.22

1.67

1.8

2.0

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

403

0.61

1.67

1.5

1.22

1.12

ratio

0.23

252

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

1.90

1.66

1.1

1.0

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

401

0.62

1.64

1.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

189

1574

1.20

1.62

2.0

—

(3035320) C reactive protein [Mass/volume] in Body fluid

571

1.32

1.58

3.5

2.6

27.54

32.12

mg/l

0.51

421

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

2.98

1.56

1.0

1.1

—

(3020650) Glucose [Presence] in Urine

263

1.47

1.52

2.2

1.8

0.00

0.02

estimate

0.80

263

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1805

18770

0.94

1.50

4.5

4.7

21.54

21.88

0.40

895

9929

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

403

0.64

1.50

1.5

0.98

0.94

ratio

0.26

252

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

403

0.64

1.50

1.5

1.19

1.17

ratio

0.06

252

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.10

1.42

1.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.71

1.42

1.2

1.0

0.02

0.04

u/ml

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.78

1.39

2.2

2.5

0.78

0.65

ug/l

0.59

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

269

1.44

1.38

1.1

9.30

3.84

u/ml

—

(40768800) Prostate Pathology biopsy report

134

1598

0.83

1.37

1.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

332

0.63

1.34

1.6

1.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

343

0.64

1.33

1.6

—

(3033099) Centromere Ab [Titer] in Serum

166

1.56

1.32

1.2

1.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

217

1.46

1.25

5.7

6.8

67.17

71.55

0.34

165

(3051387) C reactive protein [Mass/volume] in Capillary blood

184

1571

1.17

1.24

5.0

3.5

25.96

29.83

mg/l

0.95

136

1066

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.99

1.24

1.6

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

268

1.41

1.22

1.3

1.8

3.27

6.25

ug/l

0.71

196

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

249

0.60

1.20

1.3

1.5

99.02

55.57

ug/l

1.03

249

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

185

0.54

1.17

1.1

1.2

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

1.15

0.0

1.1

—

0.13

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

419

0.71

1.09

1.4

1.3

90.06

192.08

pmol/l

3.40

419

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

1.95

1.08

1.8

1.7

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

2.36

1.08

1.0

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1061

9981

1.06

1.08

5.3

4.9

35.70

33.15

8.57

729

6302

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

338

1.32

1.03

2.2

2.1

67.45

63.08

ug/min

0.04

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

5520

55523

0.96

0.99

49.5

21.8

333.63

331.38

g/l

52.63

5490

55121

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

844

8854

0.94

0.98

1.5

1.4

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.97

0.0

1.1

—

0.14

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.79

0.95

1.9

1.4

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

565

0.77

0.95

9.7

2.8

13.76

13.27

1.70

558

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

303

0.69

0.94

1.7

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

140

1.49

0.94

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.73

0.94

1.4

1.7

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.75

0.93

2.8

6.4

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

149

1.47

0.92

2.9

3.7

6.02

8.02

mg/l

0.73

123

(3041672) Baker's yeast Ab [Presence] in Serum

2.13

0.91

1.0

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

577

5360

1.07

0.89

2.7

2.2

11.04

13.38

nmol/l

8.06

482

4830

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

126

1.50

0.88

1.4

3.4

232.91

168.86

ng/l

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.85

0.86

1.1

—

(40758292) HTLV I+II Ab panel - Serum

135

1.47

0.86

1.3

1.4

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.92

0.83

1.5

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

220

1.35

0.83

1.0

1.1

90.40

95.14

0.53

168

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

327

0.73

0.81

1.1

25.94

21.18

u/ml

—

121

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

379

1.26

0.80

1.0

1.1

8.03

9.14

iu/ml

0.14

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

301

1.29

0.78

6.2

6.7

50.88

216.03

ug/l

0.81

183

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

106

1.50

0.76

1.0

17.59

36.53

iu/ml

1.28

106

(3039744) RNA polymerase III Ab [Units/volume] in Serum

1.69

0.75

1.1

1.0

—

6.00

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

277

1.29

0.75

1.1

1.0

—

(3001729) Color of Synovial fluid

1.65

0.74

1.4

1.9

—

(3034426) Prothrombin time (PT)

183

1.36

0.72

1.3

1.2

27.24

28.60

0.52

183

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

167

1.37

0.70

1.2

1.3

0.72

67.41

mg/l

0.99

129

(3038071) Oxygen [Partial pressure] in Mixed venous blood

134

1.41

0.68

17.3

6.5

6.72

5.16

kpa

1.18

134

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.84

0.68

1.2

1.0

—

(3027035) Albumin [Mass/time] in 24 hour Urine

1.56

0.63

1.2

1.4

—

316.53

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.54

0.60

1.2

1.0

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

699

0.85

0.59

1.2

8.66

7.72

mmol/l

1.34

598

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.59

0.0

1.0

—

8.19

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.65

0.56

1.3

223.33

324.92

umol/24h

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.65

0.56

1.3

1.4

—

(3006462) Nitrate [Presence] in Urine

362

1.21

0.56

5.1

3.7

—

(3034092) Cytoplasmic Ig cells/cells in Blood

1.50

0.54

31.1

7.7

0.31

0.24

0.36

(3025018) Bordetella pertussis Ab [Titer] in Serum

346

1.21

0.53

1.2

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

165

1786

0.91

0.53

2.0

1.8

52.77

43.28

nmol/l

3.31

158

1730

(4211845) Urine protein measurement

392

1.19

0.53

5.2

3.6

—

(3036670) Protein [Mass/volume] in Synovial fluid

275

1.23

0.52

1.3

1.2

38.42

39.45

g/l

0.16

141

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

171

1845

0.92

0.51

1.4

1.3

—

(3008898) HLA-B27 [Presence]

158

1702

0.92

0.47

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

333

1.19

0.47

4.5

4.2

53.60

57.55

u/ml

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.42

0.47

1.1

1.0

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

252

1.22

0.46

1.0

1.1

3.95

1.64

u/ml

0.30

(3015076) Soybean IgE Ab [Units/volume] in Serum

216

1.24

0.46

1.0

1.1

0.30

4.67

u/ml

0.85

(3026470) Cobalt [Mass/volume] in Blood

565

1.14

0.46

2.2

2.1

3.04

3.92

ug/l

0.52

526

(44806071) Cardiolipin IgM antibody measurement

1.46

0.45

1.2

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

263

1.21

0.44

1.1

0.60

1.08

u/ml

0.62

(44806420) Estimation of glomerular filtration rate

627

1.12

0.41

2.6

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.94

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

132

1418

0.92

0.40

2.3

1.8

174.68

205.65

pmol/l

2.19

114

1339

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.34

0.39

1.2

1.7

—

(3022475) Manganese [Moles/volume] in Blood

1.38

0.38

1.4

0.16

umol/l

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.32

0.33

1.2

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

162

1.23

0.33

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.26

0.29

1.0

1.1

0.77

0.58

u/ml

—

(4133840) Spirometry

171

0.81

0.27

1.7

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

809

1.08

0.27

1.1

—

(3025130) Human papilloma virus identified in Specimen

694

0.91

0.27

1.7

—

(3025577) Chromium [Mass/volume] in Blood

552

1.10

0.27

2.3

2.1

1.75

2.46

ug/l

1.37

460

(40765096) Chromosome analysis panel by Banding

269

1.14

0.26

1.2

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

103

1.25

0.26

6.8

6.6

9.60

10.13

0.58

103

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

204

1.17

0.26

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

812

1.08

0.26

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.29

0.25

1.8

1.6

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.31

0.23

1.0

2.9

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

103

963

1.06

0.22

1.2

1.1

0.67

1.76

u/ml

3.17

543

(3012494) Peanut IgE Ab [Units/volume] in Serum

135

1.18

0.20

1.0

1.1

0.65

8.69

u/ml

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

372

1.09

0.19

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.74

0.17

1.8

2.5

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

119

1.17

0.16

3.4

2.1

9.10

506.66

pmol/l

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.10

0.15

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

591

1.06

0.14

1.1

4.14

3.91

u/ml

0.03

263

(40762814) Titanium [Mass/volume] in Blood

168

1.12

0.14

2.1

2.4

3.95

3.87

ug/l

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

729

0.95

0.13

1.2

1.1

0.51

1.14

u/ml

1.64

375

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

132

1269

1.03

0.12

4.8

3.9

43.52

47.67

u/ml

0.11

126

1227

(3014133) Dog dander IgE Ab [Units/volume] in Serum

633

0.96

0.10

1.1

2.44

3.45

u/ml

0.54

309

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

217

0.91

0.10

1.3

12.20

11.28

mm/h

0.12

217

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

374

1.06

0.10

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

542

1.04

0.09

1.1

0.10

0.28

u/ml

1.44

194

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

133

1351

0.98

0.08

1.4

1.5

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.10

0.08

1.1

1.2

6.21

6.26

mmol/l

—

(1617658) Protocol used for examination of sentinel lymph nodes

585

1.03

0.07

1.0

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

783

1.03

0.06

1.1

0.47

0.84

u/ml

0.83

359

(3003888) Timothy IgE Ab [Units/volume] in Serum

803

1.03

0.06

1.1

2.69

3.55

u/ml

0.34

419

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

197

1.06

0.05

1.4

1.3

18.00

33.96

2.07

134

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

191

1.04

0.01

1.2

1.3

—

(3051101) Glucose [Moles/volume] in Cord blood

138

1.01

0.00

4.9

5.7

8.14

8.27

mmol/l

0.06

138

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

264

1.01

0.00

1.0

1.2

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

157

1.01

0.00

1.2

1.5

1.91

2.25

ug/l

—

(40768793) Breast Pathology biopsy report

189

1871

1.00

0.00

1.4

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

135

1.03

0.00

1.2

1.0

5.85

9.66

u/ml

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

-0.00

0.0

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.94

-0.00

1.2

1.5

0.60

0.50

e9/l

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

-0.00

0.0

1.2

—

0.38

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.89

-0.00

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

2701.13

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

-0.00

0.0

1.0

—

0.52

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

-0.00

0.0

1.0

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

0.00

-0.00

0.0

1.1

—

0.78

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

1.34

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

7.1

—

0.21

—

(3009992) Blasts/cells in Bone marrow

0.00

-0.00

0.0

1.9

—

10.63

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint E4_HYPOOSMNAT and mortality.

Females

Parameter	HR [95% CI]	p-value
E4_HYPOOSMNAT	1.818 [1.65, 2.01]	< 0.001
Birth year	0.994 [0.99, 1.0]	0.155

During the follow-up period (1.1.1998 — 31.12.2019), 18945 out of 38171 females with E4_HYPOOSMNAT died.

Males

Parameter	HR [95% CI]	p-value
E4_HYPOOSMNAT	3.849 [3.34, 4.44]	< 0.001
Birth year	0.986 [0.98, 1.0]	0.004

During the follow-up period (1.1.1998 — 31.12.2019), 10179 out of 20213 males with E4_HYPOOSMNAT died.

Mortality risk

Mortality risk for people of age

years, who have E4_HYPOOSMNAT.

N-year risk	Females	Males
1	0.202%	0.881%
5	0.978%	4.201%
10	2.405%	10.121%
15	4.636%	19.417%
20	8.313%	30.311%

Relationships between endpoints

↥

Index endpoint: E4_HYPOOSMNAT – Hypo-osmolality and hyponatraemia

GWS hits: 3

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Hypo-osmolality and hyponatraemia

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints